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Summary 
The human gastrointestinal tract (GIT) is a complex organ system, and is closely associated 
with immunological and hormonal functions. A delicate balance needs to be maintained 
between the selective and beneficial colonization of allochthonous and autochthonous 
microorganisms, which contribute to the preservation of gut homeostasis and protect the host 
against infections. Lactobacillus reuteri HFI-LD5 and Lactobacillus rhamnosus HFI-K2, 
isolated from the feces of healthy humans, formed biofilms on a hydrophobic abiotic surface 
(polystyrene) under static conditions and were selected for further studies. Meaningful 
differences in cell surface properties were observed between the isolates, with strain HFI-K2 
exhibiting a significantly greater basic surface property, in addition to a significantly higher 
surface hydrophobicity (37.71 %, p˂ 0.05) compared to that recorded for strain HFI-LD5 (8.82 
%, p˂ 0.05). The hydrophobic nature of L. rhamnosus HFI-K2 in conjunction with better 
biofilm formation, may contribute to a greater GIT colonization ability. Neither of the two 
strains isolated degraded mucus, and their growth was not irreversibly inhibited when exposed 
to acidic conditions (pH 2.5) and bile salts (0.5 % and 1.0 % w/v), suggesting that they may 
survive conditions in the GIT.  
To confirm planktonic and sessile survival of L. rhamnosus HFI-K2 and L. reuteri HFI-LD5 
in the human GIT, the effect of three simulated, fasting-state gastrointestinal fluids (gastric 
fluid, pH 2, 2 h exposure; intestinal fluid, pH 7.5, 6 h exposure and colonic fluid pH 7, 24h 
exposure) on both free-living and attached cell viability of the strains was assessed. Exposure 
to simulated gastric juice had the greatest effect on both planktonic cell viability and biofilm 
metabolic activity. The sequential introduction of the simulated gastrointestinal fluids initiated 
the detachment of biofilm biomass, accompanied by a decrease in the metabolic activity, as 
recorded by changes in CO2 production, by the use of the carbon dioxide measurement system 
(CEMS). However, as soon as the exposure was halted and sterile culture medium was 
reintroduced, the remaining biofilm biomass responded by producing CO2, followed by the 
recovery of biofilm biomass and re-establishment of pre-exposure activity within 24 h. In 
contrast to the complete loss of planktonic L. rhamnosus HF1-K2 viability after exposure to 
gastric juice, biofilms of this strain not only recovered within 24 h after exposure, but also 
exhibited increased metabolic activity after recovery. To our knowledge, this is the first study 
to assess the effect of simulated, fasting-state gastrointestinal fluids on lactobacilli biofilms. 
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Monitoring of CO2 production as a real-time indicator of metabolic activity in a biofilm 
provided insight to the differential survival responses of lactic acid bacteria under fasting-state 
gastrointestinal conditions. The ability of L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 to 
survive acid, bile and simulated gastrointestinal fluid induced stresses, coupled with biofilm 
formation under dynamic flow conditions, may contribute to improved survival and persistence 
of these strains within the human GIT. These characteristics, especially those exhibited by L. 
rhamnosus HFI-K2, are promising indicators for the application of these isolates as probiotic 
supplements. 
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Opsomming 
 
Die mens se spysverteringskanaal (SVK) is ‘n komplekse orgaanstelsel en is nou verbind met   
immunologiese en hormonale funksies. ‘n Delikate balans moet gehandhaaf word tussen die 
selektiewe en voordelige kolonisasie deur inheemse en indringer mikroörganismes, wat bydra 
tot die instandhouding van derm homeostase en die beskerming teen mikrobiese infeksies. 
Lactobacillus reuteri HFI-LD5 en Lactobacillus rhamnosus HFI-K2, geïsoleer uit gesonde 
menslike feces, vorm biofilms onder statiese toestande op ŉ hidrofobiese, abiotiese oppervlak 
(polistireen), en gekies vir verdere studies. Betekenisvolle verskille in seloppervlak eienskappe 
is tussen die isolate waargeneem, waar L. rhamnosus HFI-K2 'n aansienlik hoër basiese, tesame 
met 'n aansienlik hoër hidrofobiese, seloppervlak (37.71 % vs 8.82 %, p˂ 0.05) getoon het. Die 
hidrofobiese aard van L. rhamnosus HFI-K2 asook die beter vermoë om biofilms onder statiese 
groei te vorm, kan bydra tot beter kolonisasie van die SVK. Nie een van die twee isolate was 
daartoe instaat om slym af te breek nie. Blootstelling aan suurtoestande (pH 2.5) en galsoute 
(0.5 % and 1.0 % w/v) het nie ‘n noemenswaardige effek op enige van die isolate gehad nie, 
wat verder dui op die potensiaal om oorlewing onder SVK toestande.  
 
Om oorlewing in die SVK te bevestig, is die effek van drie gesimuleerde, vastende staat SVK 
vloeistowwe (maagvloeistof, pH 2, 2 h blootstelling; dermvloeistof, pH 7.5, 6 h blootstelling 
en kolonvloeistof pH 7, blootstelling 24 h) op die lewensvatbaarheid van beide vrydrywende 
en oppervlak-geassosieerde selle van beide isolate bepaal. Blootstelling aan gesimuleerde 
maagvloeistof het die grootste invloed op die lewensvatbaarheid van beide vrydrywende en 
biofilm-geassosieerde metaboliese aktiwiteit getoon. Blootstelling van L. reuteri HFI-LD5 en 
L. rhamnosus HFI-K2 biofilms aan hierdie toestande het die verlies van biofilm biomassa 
geïnisieer, en was vergesel deur 'n afname in metaboliese aktiwiteit, soos bepaal deur 
veranderinge in CO2-produksie deur die gebruik van die CO2 meting stelsel (CEMS). Sodra 
blootstelling gestaak is deur die invloei van steriele groeimedium, het die oorblywende biofilm 
biomassa gereageer met produksie van CO2, gevolg deur die herstel van biofilm biomassa en 
hervestiging van voorblootstelling aktiwiteit binne 24 uur. In teenstelling met die volledige 
verlies van vrydrywende L. rhamnosus HF1-K2 lewensvatbaarheid na blootstelling aan 
maagsap, het oppervlak geassosieerde selle van hierdie stam nie net herstel binne 24 uur na 
blootstelling nie, maar verhoogde metaboliese aktiwiteit na herstel getoon. Sover ons kennis 
strek, is hierdie die eerste studie om die invloed van gesimuleerde, vastende staat SVK 
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vloeistowwe op melksuurbakterie biofilms te evalueer. Die gebruik van CO2 produksie as 'n 
riële aanwyser van biofilm metaboliese aktiwiteit bied insig in die differensiële 
oorlewingsreaksie van melksuurbakterieë onder gesimuleerde vastende staat maag kondisies. 
Die vermoë van beide L. reuteri HFI-LD5 en L. rhamnosus HFI-K2 om suur, gal en 
gesimuleerde maagvloeistof-geïnduseerde spanning te oorleef, tesame met die vermoë om 
biofilms te vorm onder dinamiese vloeitoestande, kan bydra tot verbeterde oorlewing en 
voortbestaan van hierdie stamme in die menslike SVK. Hierdie eienskappe, veral dié van L. 
rhamnosus HFI-K2, is belowende aanwysers vir die inkorporering van hierdie isolate in 
probiotiese aanvullings.  
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Introduction 
 
This study involved two distinct fields in microbiology, i.e. probiotics and biofilms. These two 
distinct research fields were combined to allow the investigation of in vitro biofilms formed by 
probiotic bacteria. The intent was to establish a novel and improved understanding of biofilms 
formed by probiotic bacteria, since studies involving this topic are sparse and the overall 
comprehension of potential biofilm formation by probiotics lags behind that of other biofilm fields.  
 
A thorough scientific investigation into the ability of different probiotic, lactobacilli strains to form 
biofilms, and the consequent potential for improved GIT persistence associated with this surface-
attached form of microbial growth, is lacking. This knowledge gap, therefore, provided valuable 
research questions that were addressed in this study. The ability of different lactobacilli strains to 
form biofilms under static conditions has to some degree been evaluated, using the widely-
accepted microtiter screening assay. However, this does not provide a realistic simulation of the 
environmental conditions that gastrointestinal-associated biofilms experience or resolve the 
question whether probiotic microorganisms can form biofilms under conditions of flow. 
 
The isolation of novel and distinctly different species of lactobacilli, originating from human 
luminal content, was critical for this study. Previous static, microtiter lactobacilli biofilm studies 
have alluded to species and even strain specific variations. The differences identified between 
these species provided insight into the potential variation in biofilm forming abilities of probiotic 
lactobacilli. The characterization of these isolates with respect to cell surface hydrophobicity and 
auto-aggregation ability led to further understanding of the potential relevance of these routine 
probiotic-screening criteria to biofilm formation under static and dynamic conditions. Therefore, 
this study sought to investigate not only static biofilm formation by lactobacilli, but moreover the 
ability to form biofilms under dynamic flow conditions, such as found in the GIT. This is more 
pertinent to human gastrointestinal conditions where probiotics exert their beneficial effects.  
 
The differential response of planktonic and sessile microbial populations has been well established 
in the field of biofilm research and cannot be ignored. This is especially relevant to probiotics with 
respect to the general stress response induced by detrimental environmental conditions, such as 
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those experienced within the human gastrointestinal tract (GIT). The secondary focus of this study 
was to determine whether this documented differential survival response is also relevant to the 
probiotic field. To circumvent the ethical considerations required in obtaining human 
gastrointestinal fluids, simulated fasting-state gastrointestinal fluids were utilized to realistically 
mimic the harsh environmental conditions that are prevalent in the human GIT (pH changes, bile 
and enzymatic damage). The use of these biologically relevant fluids facilitated investigating the 
in vitro survival response of both planktonic and sessile populations of lactobacilli following 
exposure to GIT-relevant conditions.  
 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 6 
Significance and motivation for this study 
 
Probiotic supplements are a multi-billion-dollar industry, with the field of probiotic research at the 
forefront of scientific research and development owing to recent insights into importance of 
gastrointestinal health. Despite the advances made to date, most probiotic researchers and by 
extension the probiotic industry, have ignored a critical aspect of microorganisms, namely the 
propensity of microbes to persist as attached or sessile populations. The vast majority of past and 
present probiotic research has been conducted on planktonic microbial populations, despite the 
fact that it has been established that free-floating suspensions are not the dominant mode of 
microbial growth. This deficiency in knowledge and understanding with respect to probiotic 
biofilms is made evident by the limited number of original scientific articles addressing this topic. 
Therefore, it is of critical importance that probiotic microorganisms be studied not only 
planktonically, as it relates to the preparation and packaging of probiotic supplements, but also as 
biofilms, since probiotics are expected to associate with surfaces in the human GIT.  
 
 
Classical screening methods to identify strains with potential probiotic properties involve 
subjecting the planktonic cells to acidic and bile-enriched conditions. Although this technique may 
detect putative probiotic strains, it is entirely synthetic and lacks the biological relevance that is 
required to adequately simulate the gut. Conversely, the use of human subjects and/or their 
gastrointestinal fluids create significant ethical considerations and provide a notable barrier to 
probiotic research. A middle-ground approach thus involves the use of simulated human 
gastrointestinal fluids consisting of biologically relevant compounds at appropriate concentrations. 
In this study, the use of simulated fasting-state gastrointestinal fluids to mimic the stresses induced 
on bacterial biofilms allowed for greater insight into potential probiotic survival and persistence 
within the human GIT. 
 
 
The ability to assess the response of bacterial biofilms to metabolic stress is critical and provides 
insight into how these communities may function within the natural environment. The use of 
carbon dioxide as an indicator of biofilm metabolic activity allowed for the real-time analysis of 
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bacterial biofilm formation and response to adverse conditions. The combined usage of metabolic 
activity monitoring and simulated gastrointestinal fluids permitted the investigation of the survival 
and potential persistence of probiotic biofilms in vitro. To our knowledge, this is the first study to 
assess the effects of simulated fasting-state gastrointestinal fluids on biofilms formed by 
Lactobacillus species.  
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Research questions 
 
Several research questions were addressed in this study, namely: 
 
Do planktonic lactobacilli cells exposed to low pH and bile salt stress (classical probiotic screening 
techniques) differ in survival compared to planktonic cells exposed to biologically relevant 
gastrointestinal fluids?  
 
Does static biofilm formation by different lactobacilli, isolated from human luminal contents, 
differ? 
 
Does surface hydrophobicity and auto-aggregation contribute to the ability of bacteria to form 
biofilms? 
 
Do planktonically cultured populations of lactobacilli differ in survival after exposure to simulated 
fasting-state gastrointestinal fluid compared to sessile populations? 
 
If simulated fasting-state gastrointestinal fluids disturb lactobacilli biofilms cultured under flow 
conditions and induced severe metabolic stress, would these biofilms recover upon amelioration 
of the unfavorable environmental conditions induced by the fluids?  
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Overview of chapters 
 
The human body is a complex system comprised of multiple organs, with the gastrointestinal tract 
(GIT) being solely responsible for the acquisition of nutrients critical to the maintenance of overall 
homeostasis. The first chapter provides an overview of the underlying complexity of the human 
GIT by providing insight into the anatomical, physiological and microbial parameters that 
contribute to the complex nature and function thereof. A brief summary of probiotic supplements 
and its history is included, along with probiotic selection criteria and tolerance of probiotic bacteria 
to GIT conditions. The relevance and occurrence of bacterial biofilms in the human GIT is also 
discussed. The chapter is concluded with a summary of various model systems used to simulate 
the human GIT, with specific focus on simulated gastrointestinal fluids.  
 
The physiological processes that govern the human body are controlled by homeostatic regulation 
and the human body must maintain a fine balance between the prevention infection and beneficial 
colonization by allochthonous and autochthonous microorganisms. In the second chapter, two 
novel lactobacilli, namely Lactobacillus reuteri HFI-LD5 and Lactobacillus rhamnosus HFI-K2, 
isolated from human feces, were examined for their suitability as probiotic supplements. Classical 
probiotic screening methods were employed to compare the isolates with respect to predefined 
criteria, including bile tolerance, mucinolytic activity, auto-aggregative ability and cell surface 
hydrophobicity. The performance of the novel isolates was benchmarked against that of two 
commercially available probiotic supplements. In addition to these desirable probiotic 
characteristics, the ability of the two lactobacilli isolates and commercial strains to form static 
biofilms on hydrophobic abiotic surfaces, under various nutrient conditions, was also evaluated.  
Complex and diverse intra- and inter-species interactions take place within the human GIT. Gut 
microbiota research, including that involving probiotics, predominately focus on microbes in 
suspended or planktonic growth rather than sessile or biofilm-associated cells. In the third chapter, 
the effects of three simulated, fasting-state gastrointestinal fluids on the viability of both planktonic 
and sessile cells of the two lactobacilli isolates (L. reuteri HFI-LD5 and L. rhamnosus HFI-K2) 
were assessed. Real-time monitoring of biofilm metabolic activity provided insight into whether 
any differential survival responses exist between planktonic and sessile populations of the 
respective lactobacilli strains under simulated fasting-state gastrointestinal conditions.  
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CHAPTER 1: Literature Review 
 
1.1. The gastrointestinal tract 
 
The human gastrointestinal tract (GIT) is an intricate body system, fulfilling a critical role with 
respect to immunological and metabolic functions (1, 2). The GIT is more than just a collection of 
tissues but rather represents a fine balance between eukaryotic and prokaryotic interactions. It is 
the most heavily colonized body system, with approximately 70 % of all microorganisms found in 
and on the human body residing within the colon (3). The human GIT provides a diverse variety 
of environmental niches, governing the selective colonization of these anatomically and 
physiologically distinct sites. Microbial colonization at birth has a significant impact on shaping 
the development of the gut microbiota and has long-term effects on human development and the 
maintenance of homeostasis.   
 
The human gastrointestinal tract has a surface area in excess of 32 m2 which, combined with the 
physiological parameters present, creates an ideal environment for microbial colonization (4). The 
human body is colonized by 10 to 100 trillion microbial cells, representing 2 to 3 % of total body 
weight and out numbering human cells by 10-fold (5–7). The two major sections of the GIT, 
namely the upper and lower GIT, represent anatomically and physiologically distinct 
environments. These two sections contain 4 environmental niches: the oral cavity, stomach, small 
intestine and colon. 
 
The fetal and infant GIT was thought to be essentially devoid of microorganisms and is 
immediately colonized at birth by various microorganisms (6, 8). It is generally believed that an 
infant’s GIT is naturally colonized with microorganisms from the uterus and vagina during birth 
(9).  However, more recent studies have shown the presence of bacteria in the placenta (10) and 
amniotic fluid (11–14) before birth, in blood sampled from the umbilical cord (15) and fetal 
membranes of healthy newborns (13, 14, 16), suggesting that the intestinal tract of the fetus is 
colonized when still in the womb. This represents the first major gut microbial community 
succession, which is dependent on factors such as mode of birth (cesarean section or vaginal birth), 
diet (formula or breastfed) and environmental conditions (hospital or home birth) (6, 8). It has been 
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scientifically shown that this initial colonization is critical and influences the final, stable adult 
microbiota (17). If initial colonization is examined, you begins to understand the importance and 
influence of environmental factors on microbial populations within the GIT. This is exemplified 
by the contrast that exists between modes of birth. Birth by Cesarean section prevents the contact 
that the infant would have had with the birth canal and the associated vaginal microbiota and 
instead exposes the infant to the mother’s skin microbiota. This is evident in the increased 
prevalence of skin-associated staphylococci in the GIT of cesarean-delivered infants (8). A 
decrease in Bifidobacterium and Bacteroides numbers, an increase in clostridial species, along 
with smaller numbers of Escherichia coli have also been observed, in conjunction with an overall 
reduction in bacterial diversity (8, 18). In contrast, infants delivered via the birth canal are 
colonized by the vaginal and intestinal microbiotas, which contain strict anaerobes largely absent 
in cesarean born infants (19).  
 
The second major gut microbial community succession occurs when infants are weaned. The 
microbial population increases in diversity and starts to resemble the population common in adults 
(8, 20). A resilient and stable adult-like gut microbiota is achieved at 3 to 5 years of age and tends 
to be stable throughout adulthood (17, 21). Colonization of the infant gut plays a pivotal role in 
immunological and metabolic functionality and also affect disease susceptibility later in life (6, 8, 
17, 20).  
 
1.2. Anatomical, physiological and microbial parameters of the GIT 
 
The GIT is broadly defined as a hollow, muscular tube extending from the oral cavity to the anus 
(22, 23). It can be divided into 4 distinct sections, with the inclusion of accessory organs (gall 
bladder etc.) further complicating the physiology and microbiota of this system. 
 
1.2.1. Upper GIT 
 
The upper GIT is comprised of the oral cavity, esophagus and stomach with the exact anatomical 
distinction between the upper and lower GIT being at the suspensory muscle of the duodenum 
(24). This region of the GIT is responsible for the initial digestion of dietary components, starting 
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within the oral cavity and ending with stomach. The upper GIT provides numerous environmental 
niches. It is dominated by three genera, Streptococcus, Gemella and Bacteroides (25), while phyla 
such as Firmicutes, Proteobacteria and Fusobacteria constitute a smaller fraction of the microbiota. 
The dramatic changes in pH and enzyme concentration within the upper GIT provide a significant 
hurdle to the survival of microorganisms.  
 
Oral Cavity and Esophagus 
 
Although the primary purpose of the oral cavity is the ingestion and mastication of food, secondary 
functions such as limited digestion of carbohydrates through amylase activity and the absorption 
of small molecules (e.g. glucose) through the mucosal wall also take place (23, 26). The oral cavity 
extends externally from the lips and cheeks to the anterior pillars of the fauces internally, and 
extends downwards from the hard and soft palates to the tongue (23). The oral cavity is lined with 
stratified, keratinised squamous epithelial cells, to protect against microbial adhesion during 
mastication (27). Mastication is achieved through the mechanical action of the 32 teeth present in 
the adult human mouth, and the masticated food mixture leads to insalivation once combined with 
saliva (23). Saliva is a complex, highly viscoelastic fluid comprising 99 % water, with the 
remaining constituents primarily consisting of proteins (mucin, amylases and antimicrobial agents) 
and ionic components (23, 28). The pH of saliva is near neutral (6.2 to 7.6), and the flow rate is 
governed by stimulated and unstimulated states to 2.0 ml.min-1 and 0.3 ml.min-1, respectively (23, 
29). Upon completion of mastication, the partially digested and homogenized food bolus enters 
the esophagus via the pharynx. The esophagus moves the bolus from the oral cavity to the gastric 
compartment via peristalsis (23, 28).  
 
The human oral cavity provides a distinct niche, containing various microenvironments (30, 31). 
The near neutral pH and nutrient rich environment encourages microbial colonization by 
endogenous and exogenous microbes. The oral microbiota consists of in excess of 700 species, 
with a high degree of diversity (25, 30, 31). It is home to six phyla, namely Firmicutes, 
Actinobacteria, Proteobacteria, Bacteroidetes, Fusobacteria and TM7 (30, 31). Even though the 
Firmicutes phylum is one of the smallest, it is extremely diverse. For example, the genus 
Lactobacillus shows a large degree of species diversity within the oral cavity, with the reported 
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isolation of Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus 
crispatus, Lactobacillus fermentum, Lactobacillus gasseri, Lactobacillus paracasei, Lactobacillus 
plantarum, Lactobacillus rhamnosus, Lactobacillus salivarius and Lactobacillus vaginalis. These 
species are considered to be autochthonous to the oral cavity (32), with L. acidophilus being the 
most dominant Lactobacillus sp. in the oral cavity (33). The rapid transit time from mouth to 
esophagus limits proliferation of planktonic microbes within the oral cavity and provides a 
continuous inoculum for the rest of the GIT.  
 
The rapid transit of the bolus through the relatively short esophagus, ensures minimal colonization. 
The esophageal microbiota is similar in composition to that of the oral microbiota (34). The same 
six phyla dominate (Firmicutes, Bacteroides Actinobacteria, Proteobacteria, Fusobacteria, and 
TM7) with Streptococcus being the numerically dominant genus (39 %) (35). The similarities 
between the oral and esophageal microbiota may be attributable to the periodic inoculation of the 
esophagus by the bolus.  
 
The secondary phase of digestion takes place within the confines of the stomach or gastric 
compartment. 
 
Stomach 
 
The human stomach is an impressive and intricate organ, facilitating complex processes such as 
nutrient absorption, partial digestion and partial exclusion of some microbial pathogens within the 
GIT. The stomach, with its acidic gastric fluid, facilitates the partial digestion of complex food 
into various dietary components and the absorption of select components including some 
medication and ethanol (36). The human stomach is a hollow, muscular, expanding organ, 
comprised of 4 regions (fundus, gastric body, pyloric antrum and pylorus) (23, 28). The stomach 
provides a surface area of approximately 0.05 m2 when fully distended, holding about 1 000 ml of 
gastric contents (4). The gastric wall is complex in structure and is comprised of mucosa (surface 
epithelium, lamina propria and muscularis mucosae), which contains various gastric glands 
(secretory epithelial cells) (23). 
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The gastric glands are responsible for the secretion of mucin, pepsinogen, hydrochloric acid, 
intrinsic factor, bicarbonate and gastrin (23, 28, 37, 38). The gastric fluid is an acidic cocktail of 
hydrochloric acid, enzymes and mucus, which facilitates partial digestion of complex foods. The 
pH of gastric fluid varies between pH 1.0 and pH 5.0, depending on the nature of the stomach 
content (38, 39). During the fasting-state the pH of the stomach contents decreases to below 2. The 
introduction of the bolus into the stomach causes a temporary increase in gastric pH, to within the 
range of pH 4.0 to 7.0 (40). The buffering capacity of the bolus during fed-state provides a 
temporary reprieve from the highly acidic conditions, followed by a steady decrease to fasting-
state pH values within 2 hours post feeding (41). The gastric enzyme, pepsin, is one of the major 
digestive enzymes, and is tailored specifically for the hydrolysis of exogenous proteins. While it 
is inactive at near neutral pH, it functions optimally at pH 2.0 (42, 43). Lingual lipase is another 
digestive enzyme present in the stomach, and it is responsible for the hydrolysis of medium- and 
long-chain triglycerides (44, 45). In contrast to pepsin, lingual lipases function optimally at a pH 
range of between 3.0 and 6.0 (45).  
 
The near-constant acidic condition and presence of gastric enzymes within the stomach, is critical 
for partial digestion of complex food matrixes. This stringent environment necessitates the 
protection of the secretory epithelial layer containing the gastric glands. The surface of the 
secretory epithelial cells are coated with a protective 200 µm-thick viscous, polymeric-gel layer, 
comprised of two layers of mucus (46, 47). The dense inner layer is firmly attached to the secretory 
epithelium and gives rise to the loose, thicker outer mucus layer (4 to 5-fold thicker) through the 
activity of endogenous proteases (47). The gastric mucosal surfaces are protected by two main 
mechanisms; high cell/mucus turnover rates and acid neutralization. Turn-over rates within the 
stomach are fast, with the entire gastric mucosa being renewed every 3 to 54 days (dependent on 
cell types) (48). The inner gastric mucus layer is renewed hourly by the goblet cells, allowing for 
the constant expansion of this layer to replenish the outer mucus layer to ensure a protective barrier 
(49). Acid-neutralization at the luminal surface of the epithelial cells is achieved through the 
secretion of bicarbonate by the gastric mucosa (50). The bicarbonate is encased in the mucus 
layers, and although it provides limited buffering capacity, it maintains the surface of the 
epithelium at pH 7.0 (50, 51). These mechanisms maintain a balance between digestion and auto-
digestion under homeostatic conditions.  
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Mixing within the stomach and the movement of food from the stomach to lower GIT is achieved 
through peristaltic muscular contraction of stomach walls (52). This rhythmic peristaltic 
movement gives rise to laminar flow conditions with a low Reynolds number, i.e. smooth and 
gentle movement (52, 53). Gastric transit times are unique to a specific individual and also 
dependent on the nature of the stomach contents. The interval from the time of entry of the bolus 
through the esophageal sphincter, to the exiting of the chyme (mixture of digestive enzymes and 
partially digested food) through the pyloric sphincter varies from 15 min to in excess of 120 min 
(54–58).  
 
The stomach is a harsh environment to colonize, with constant acidic conditions and enzymatic 
activity. As a result, microbial diversity in the stomach is relatively low compared to the rest of 
the GIT (59, 60). The stomach microbiota is mainly comprised of three phyla; Firmicutes, 
Proteobacteria and Bacteroidetes, in descending order of dominance (61). The presence of the 
mucus bilayer creates two distinct microenvironments within the stomach. The outer thick, loose 
mucus layer is colonized by non-acidophilic bacteria, e.g. Helicobacter spp. (60). The presence of 
Helicobacter spp. decreases overall diversity within the stomach (60). Acid-tolerant species of 
Lactobacillus, Staphylococcus, Streptococcus and Neisseria are frequently present (60). The 
human stomach is generally devoid of large numbers of lactobacilli, however studies of the 
stomach microbiota have revealed the presence of various species of lactobacilli such as L. 
fermentum, gasseri, reuteri, salivarius and vaginalis (32, 62, 63). Roos et al. (62) isolated four 
novel Lactobacillus spp. from gastric biopsies, Lactobacillus antri, Lactobacillus gastricus, 
Lactobacillus kalixensis and Lactobacillus ultunesis, which alludes to the adaptation of some 
Lactobacillus spp. to the harsh conditions prevalent in the stomach. The gastric microbiota more 
closely resemble the lower GIT microbiota than that of the oral microbiota (61). 
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1.2.2. Lower GIT  
 
Starting at the pyloric sphincter and terminating with the anus (64), the small intestine and colon 
constitute the lower GIT in humans. It is the region where the majority of digestion and absorption 
of nutrients occurs. The lower GIT environment is physiologically more conducive to microbial 
colonization and persistence. This is primarily due to the near-neutral pH, slower transit time, and 
presence of microenvironments in the crypts and mucus layers. However, although it is relatively 
favorable for microbial colonization, significant chemical barriers such as the presence of bile salts 
and digestive enzymes need to be overcome.   
 
Small intestinal tract 
 
The small intestine is the site where digestion is completed and adequate nutrient absorption starts. 
The anatomical start point of the small intestine is below the pyloric sphincter and it terminates at 
the ileo-caecal valve (23). The small intestine can be defined as a hollow, invaginated, muscular 
tube and is comprised of 3 anatomical regions; the duodenum, jejunum and ileum (22, 23). In 
contrast to the stomach mucus layer, the small intestinal mucus layer is singular in nature and lacks 
the dense, firmly attached inner layer present in the stomach (47). The single mucus layer is not 
permanently attached to the epithelial layer but rather loosely associated with the surface (47). The 
mucus layer lubricates the transit of chyme, traps microorganisms and neutralizes the chyme 
exiting from the stomach. Bicarbonate, produced by the Brunner glands located in the mucosa, is 
responsible for neutralization (65). The quantity of bicarbonate produced by the Brunner glands is 
more than 6 times the amount that is produced within the stomach, and increases the chyme pH 
from 2.0 to 3.0 to pH 6.5 to 7.5 (51). A rapid increase in chyme pH to ± 6.0 is facilitated upon 
entry into the duodenum and is further elevated during transit through the jejunum and ileum to a 
final pH of 7.5 (40, 66).  
 
Owing to its function, the intestinal mucosa is thicker and more vascular than the gastric mucosa  
(23). Circular folds, or plicae circulares, protrude into the lumen due to the underlying submucosa 
forming ridges (23, 67). The intestinal surface area is further increased by intestinal-villi, 
microvilli and glands (67). The presence of plicae circulares, villi and microvilli facilitate the bulk 
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absorption of nutrients within the GIT, even though the small intestine is only 6 m in length (67). 
The surface area of the entire small intestine is 400 times greater than that of the stomach (30 m2 
versus 0.05 m2). This significant difference in surface area can be attributed to the intestinal villi 
and microvilli increasing the surface area by 6.5 and 13 times respectively (4). This vast surface 
area is critical for absorption and secretion, in addition to interactions with eukaryotic and 
prokaryotic organisms.  
 
The small intestinal secretions include enzymes and surfactants. Upon entry into the duodenum, 
the chyme is combined with pancreatic fluid originating from the pancreas and bile produced by 
the liver (67). Pancreatic fluid possesses a dual functionality of neutralizing chyme to provide the 
optimal environment for pancreatic enzyme function and reducing acid damage to intestinal 
mucosa (67). Pancreatic amylases complete the digestion of carbohydrates started by salivary 
amylase in the upper GIT (67). Large protein fragments generated in the stomach through gastric 
enzymatic activity, are further degraded to smaller peptides by pancreatic proteinases (trypsin and 
chymotrypsin) (67). Bile is a complex secretion with both excretory and digestive functions (68). 
Bile is constantly produced within the liver and stored within the gallbladder, prior to secretion 
into the duodenum (67, 68) and its concentration within the small intestinal lumen ranges from 0.2 
to 2.0 % (w/v) (69). As a digestive aid, bile acts as a surfactant and emulsifier for subsequent 
absorption of fats and lipophilic vitamins from the chyme (70). Bile also has a tertiary function as 
an antimicrobial agent, due to its bacteriostatic action which reduces the colonization ability of 
allochthonous microorganisms (68).  
 
The chyme is propelled through the small intestine by a combination of segmentation (bidirectional 
movement) and peristalsis (unidirectional movement) (67). Segmentation functions predominantly 
to homogenize the chyme and intestinal secretions, and achieves only a small amount of forward 
propulsion. Conversely, peristalsis (wave-like muscular contractions) has limited homogenizing 
activity but is the primary mode of propulsion of intestinal content (23, 67). The combination of 
segmentation and peristalsis yields a low Reynolds number, indicative of laminar flow conditions, 
and a transit time specific to intestinal conditions. The transit of chyme, upon entering duodenum 
to entering ascending colon, is between 0.5 and 6 h (54, 56, 71).  
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The transit of the microbial-laced bolus through the pyloric sphincter into the duodenum introduces 
the upper GIT microbial communities into the lower GIT. The composition of the communities 
entering the small intestine is largely shaped by the gastric acid and duodenal secretions containing 
bile and pancreatic enzymes (72). Chyme digestion within the small intestine causes increased 
enzymatic stress on the microbial communities present. These stresses shape the communities and 
as a result a relatively small indigenous population is prevalent in the small intestine (72). The 
dominant phyla within the small intestinal tract are Actinobacteria, Bacteroidetes, Firmicutes and 
Proteobacteria, with the following genera being prominent: Bacteroides, Clostridium, 
Eubacterium, Lactobacillus, Prevotella and Ruminococcus (59–61, 72). The diversity of 
Lactobacillus spp. within the small intestine includes some species that are not prevalent in the 
upper GIT, namely Lactobacillus delbrueckii, Lactobacillus reuteri and Lactobacillus ruminus 
(72). As would be expected, various Lactobacillus spp. present within the upper GIT are found in 
the small intestine (chyme-associated), including, L. acidophilus, casei, gasseri, paracasei, 
plantarum and rhamnosus (32, 33, 72).  
 
Colon 
 
The colon mainly ensures osmotic homeostasis and provides a microenvironment for the gut 
microbiota. It is responsible for water, electrolyte and energy recovery from digested food entering 
from the small intestine. The colon extends from the ileo-caecal valve to the anus, and is a hollow, 
muscular tube with haustrations or wall invaginations. It consists of 3 sections, termed the 
ascending, transverse and sigmoidal colon (23, 73). The colon has a similar microstructure to that 
found within the small intestine, however it lacks villi and the characteristic plicae circulares 
(circular folds) of the small intestine (23). These circular folds are replaced by semi-circular 
haustrations, small pouches caused by sacculation (sac formation), giving rise to the characteristic 
segmental form of the colon (23, 74). The luminal surface of the colon is lined with columnar 
epithelial cells, goblet (mucus) cells and microfold cells (23). These cells enable the dual functions 
of the colon as an absorptive and secretory organ. The replacement of villi with blunt microfold 
cells, as well as the relatively short length (1.5 m) of the colon, reduces the surface area to 2 m2, 
which is 15-fold lower than the surface area of the small intestine (4).  
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The colon has a mucus bi-layer that resembles that of the stomach, rather than the single layer 
present in the small intestine (75). The inner mucus layer is dense, stratified and firmly attached 
to the colonic mucosa and is impermeable to gut microbiota (75). The proteolytic degradation of 
the inner layer, causes a 4-fold expansion in thickness and the generation of the loose outer layer 
(75). The mucus bi-layer protects the underlying mucosa from damage caused by organic acid 
production due to bacterial fermentation, provides lubrication to limit abrasion by passing food 
particles, and creates an environmental niche for gut microbiota (67, 76).  
 
The colonic environment is neutral to slightly alkaline, with pH values ranging from 5.5 to 8.5, 
dependent on the section of the colon and dietary composition (37, 77). The colon is heavily 
colonized by microorganisms and the neutral pH can be temporarily decreased by the production 
of organic acids. Bacterial fermentation of the previously undigested food fraction produces short-
chain fatty acids which are used as an energy source by colonic cells (78, 79). The bicarbonate-
containing mucus bi-layer ensures that homeostatic pH conditions are maintained, thereby 
mitigating any detrimental effects of bacterial metabolites (organic acids) on the epithelial cells 
(67). The colon also recoups bile salts that escape reabsorption in the distal ileum, thus reducing 
the bile concentration within the colon (80, 81).  
 
Transit time through the colon, achieved through haustral contractions, is significantly longer than 
the transit through the rest of the GIT (67, 82). Haustral contractions fulfill the combined function 
of segmentation and peristalsis that occur in the small intestine, i.e. mixing and forward propulsion. 
Colonic transit time is typically in the range from 7 h to in excess of 24 h (67, 83).  
 
The colon is the section of the GIT best suited to microbial colonization and coincidently also the 
best-studied part of the GIT in terms of its microbial community. The microbial community 
contained within the colon is largely (90 %) comprised of obligatory anaerobic bacteria (60, 84, 
85). The colonic environment is the least hostile environment in the entire GIT, which is 
corroborated by the high microbial diversity observed here (60). Culture-based methods only 
identified a small fraction of the microbial community within the colon, with 40 species 
comprising an estimated 90 % of the culturable population (60). In stark contrast, culture-
independent methods estimate that more than 800 species are represented in the colon (60). The 
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dominant phyla within the colon, in descending order of abundance are, Bacteroidetes, Firmicutes, 
Proteobacteria and Fusobacteria (59). The abundance and diversity of lactobacilli are the highest 
within the colon, with species such as, L. casei, fermentum, paracasei, reuteri, ruminus and 
salivarius being present (32, 85). The relative microbial abundance and diversity within the colon 
remains stable over time and is less prone to community fluctuations when compared to the small 
intestine and stomach.  
 
1.3. Probiotics in a Human Context  
 
The global probiotic market size is in excess of $ 34 Billion as of 2015, and it is estimated that in 
a mere six years the market size may nearly double (86). The renewed interest in GI health and 
functional foods has driven investigations into host-microbe interactions and the effects on human 
health and disease states (87). The microbial community contained within the human GIT forms a 
complex “organ within an organ”, sometimes referred to as the “forgotten organ” (88, 89). This 
“forgotten organ” plays a critical role in human metabolism, immunological functionality and 
overall maintenance of gut homeostasis (88, 89).  
 
The large surface area of the human GIT is favorable for microbial colonization and provides a 
large and critical target for pharmaceutical and probiotic supplementation effects on the human 
body (4).  
 
1.3.1. History of probiotics 
 
Microorganisms have colonized and been an integral part of the human GIT from before the 
beginning of modern civilization (90). Although humans and microorganisms have coexisted for 
many years, scientists only took notice of the inherent health benefits of fermented dairy products 
in the 1800’s (91). The link between general human wellbeing and microorganisms was not made 
until the early 1900’s after two scientists identified two genera that were associated with the 
observed health benefits. In 1905, Eli Metchnikoff determined that the health benefits associated 
with the consumption of yogurt was not due to the yogurt, but rather the Lactobacilli that fermented 
the milk (92). A year later Henry Tissier isolated Bifidobacterium from an infant and claimed that 
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health benefits could be attributed to the bacterium (91). The three decades preceding the 1950’s 
heralded an era of probiotic discovery and screening, in which numerous potential probiotic strains 
were isolated (91). By the early 2000’s the total number of publications concerning probiotics was 
in excess of 200 a year, with an exponential increase observed over the subsequent decade, in 
conjunction with evidence-based clinical trials. (91). Since the identification of microorganisms 
as the primary source of health benefits associated with fermented foods, the probiotic field has 
been dominated by the two genera Bifidobacterium and Lactobacillus, with a few other microbes 
being identified as probiotics (e.g. Escherichia coli Nissle 1917 and Saccharomyces boulardii 
spp.) (91, 93, 94). 
 
1.3.2. Selection of Probiotic Microorganisms 
 
As previously stated, the human GIT is host to multiple species of microorganisms, however not 
all of these microorganisms are considered to be conducive to human health. Therefore, the 
selection of beneficial microorganisms is critical for the development of probiotics. Globally, no 
legislative definition exists for what constitutes a probiotic or what functions it must perform (87). 
A consensus was reached in 2001 with regards to a definition, whereby probiotics are defined as 
“live microorganisms that, when administered in adequate amounts, confer a health benefit on the 
host” (95). Three major criteria are contained within this definition; namely the potential probiotic 
needs to be metabolically active within the GIT (“live”), the number of viable microorganisms 
needs to be of significant proportion to elicit a response (“adequate amounts”) and needs to 
contribute to host’s health (“health benefit”).  
 
The ability of potential probiotic microorganisms to contribute to human health is dependent on 
them being viable within the human GIT (96–98). Probiotic candidates are intrinsically required 
to survive the rigors of the human GIT, governed mainly by the chemical conditions that are 
prevalent. Alternating acidic and the alkaline conditions, coupled with bile acids, provide a 
significant hurdle for exogenously introduced microbes to overcome (96–98). Therefore, any 
microorganism that is considered a candidate in probiotic supplementation needs to be screened 
and individually evaluated for tolerance to acidic conditions and bile-induced stress.  
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Even if the microorganism is resistant to the adverse environmental conditions within the GIT, the 
number of viable cells may be low, and the concentration of probiotic microbes has to be adequate 
to exert health benefits (99). In general, the concentration of viable cells in the supplement 
correlates with the survival rate through the GIT. Controversy around the minimal dose as well as 
frequency of administration of probiotic supplements exists, and there is no established minimal 
dose to ensure health benefits (99). As a general rule, 107 to 109 CFU.g-1 is recommended for 
clinical relevance in humans (99). This general rule however fails to account for species and strain 
variability with respect to viability, as well as the proportion of cells retained in the GIT versus 
those washed out. Therefore, further research into the dose-dependent nature of probiotics, such 
as minimal dose required for health benefits and viability purposes, and the frequency of dosage 
for each probiotic supplement is required.  
 
The health benefits associated with endogenous and/or exogenous microorganisms are vast, 
ranging from inhibition of enteric pathogens, to immunomodulation and overall maintenance of 
GIT homeostasis. The ability of microorganisms to modulate the immune system has become a 
recent focus area within probiotic research.  
 
Probiotic microorganisms have the ability to influence the host’s immune system by regulating 
and modulating the immune response (100–102). This modulation can occur on a mucosal and 
systemic level, through either interaction of the probiotic with other microorganisms contained 
within the microbiota (commensal and pathogenic) or cross-talk mediated communication between 
the probiotic and host cells (100, 101). The latter communication is mediated through Microbe-
Associated Molecular Patterns (MAMPs), which are essential, conserved structural components 
of microbial cells, such as lipoteichoic acids, nucleic acids, peptidoglycan and other cell surface 
proteins (101, 103). These MAMPs are recognized and interact with receptors on antigen 
presenting host cell surfaces, known as Pattern Recognition Receptors (PRRs), which form part of 
the innate immune system (101, 104). The MAMPs-PRRs interactions initialize a signaling 
cascade within the host, either triggering a pro- or anti-inflammatory immune response (105). The 
exact immunological influences and modulations caused by microbes, and specifically probiotic 
microorganisms, are comprehensively covered in various reviews (105–108). Through these 
mechanisms, probiotic supplements have been shown to have a beneficial effect on allergies 
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(allergic rhinitis and eczema) and asthma, which are immune-mediated diseases (100, 109). It must 
however be noted that probiotic supplementation should not be used as a primary treatment or 
prevention of immune-mediated diseases (109). 
 
Probiotic supplementation has been positively associated with the prevention and reduction of 
Antibiotic-Associated Diarrhea (AAD) (110). AAD occurs due to the ecological imbalances 
caused by the administration of antibiotic regimes, which render the entire GIT in a state of 
dysbiosis (111). AAD accounts for nearly a third of all cases of diarrhea and is broadly defined as 
unexplained incidences of diarrhea associated with the administration of antibiotics (112, 113). 
Furthermore, in excess of 20 % of AAD cases are found to be caused by the out-growth of 
Clostridium difficile within the GIT (111, 113). The recalcitrant nature of C. difficile infections 
(CDIs) are coupled with adverse health effects such as pseudomembranous colitis and sepsis (114). 
This makes the effective treatment of CDIs critical for both healthcare professionals and patients. 
Probiotic supplementation before and during antibiotic administration significantly reduces AAD 
and CDIs (113). Probiotics may achieve this through the amelioration of GIT dysbiosis, by 
blocking of attachment sites for pathogens and pathogen-derived metabolites, and inhibiting 
pathogens through antimicrobial production (111). It is notable that the mechanisms behind this 
reduction are varied and probiotic strain specific (111). Although not the perfect treatment for 
AAD, its strength lies in its capacity to be co-administered with the antibiotic regime, giving 
credence to the idiomatic phrase, “prevention is better than cure”.  
 
1.3.3. Probiotic Tolerance to GIT Conditions 
 
As previously discussed, the conditions within the human GIT are generally unfavorable for 
microbial colonization. The first significant hurdle for any microbial cell, and therefore probiotic, 
is the need to overcome the stress induced by gastric fluid conditions (low pH, rapid transit etc.) 
(37, 39). LAB are considered to be aciduric in nature, although exposure to acidic conditions such 
as those prevalent within the human stomach have a significant effect on viability (115, 116). The 
low pH of gastric fluids induces stress responses in various lactobacilli strains (i.e. acid shock 
response) with concurrent decrease in survivability (116, 117). 
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Various probiotic studies have shown that although microbial cells withstand the low pH and rapid 
transit through the stomach, it comes at a significant cost in terms of survival. A rapid decline in 
probiotic viability is seen upon exposure to gastric fluid, with some studies reporting an adverse 
response within five minutes (116). The dramatic influence of the acidic gastric fluid is clearly 
illustrated through the observation made by van Bokhorst-van de Veen et al. where a decrease in 
gastric fluid pH by as little as 0.1 units significantly influenced survival (118). Pre-exposure of 
probiotic strains to acidic conditions during growth primes cells and enhances survival upon 
exposure to the gastric environment (118). Alterations to cell wall composition (decreasing proton 
permeability), down-regulation of genes involved in basic cellular processes and up-regulation of 
proteins (chaperones) are all mechanisms employed by lactobacilli strains, such as L. casei, L. 
rhamnosus and L. reuteri to overcome acid stress (118–120). The effect of food matrices and the 
encapsulation of probiotic supplements (gelatin capsules and fillers) should be taken into account, 
since the buffering capacity of these compounds also contributes to the survival of probiotics 
within the stomach (119).  
 
Although the near-neutral pH within the small intestine provides environmental conditions more 
suited to colonization by probiotic microorganisms, the presence of bile and digestive enzymes 
may affect viability. Some studies involving L. casei, have shown that a loss in viability occurs 
only after 45 minutes of exposure to intestinal fluid (115). Furthermore, interspecies variation 
occurs among lactobacilli with respect to bile tolerance which alludes to some species being better 
equipped for survival within the small intestinal environment (32, 121, 122). The survival and 
persistence of L. reuteri strains within the GIT of mammals, including humans, has led this species 
of lactobacilli to be considered allochthonous (indigenous) to the human intestinal environment 
(32, 122). In contrast, L. rhamnosus is considered to be autochthonous, since it only seems to be a 
transient GIT resident originating instead from the oral cavity (32, 122). However, L. rhamnosus 
strains are known to rapidly transit through the upper GIT, hereby only allowing for the 
colonization of the colon (122). 
 
The colonic environment is a finely-tuned ecosystem, colonized by a stable microbial population 
(122, 123). The abundant availability of undigested and complex carbohydrates, in addition to the 
presence of deep colonic crypts provide a microenvironment for bacterial attachment and 
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protection from the flowing luminal content (124). An increase in pH, in conjunction with lower 
bile concentrations and slow transit times further facilitate colonization (39).  
 
In conclusion, the human GIT provides numerous environmental niches for the colonization and 
subsequent proliferation of probiotic microorganisms that are considered to be transient in the GIT. 
It is however to be noted that the survival of supplemented probiotics within the GIT is species 
and strain specific; it is thus essential to evaluate the survival and colonization characteristics of 
each potential probiotic within a GIT context.  
 
1.3.4. The genus Lactobacillus  
 
The order Lactobacillales or Lactic Acid Bacteria (LAB) comprises Gram-positive, catalase 
negative, non-sporulating, low G + C content bacteria (125, 126). LAB consist of 13 genera, 
namely Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, 
Oenococcus, Pediococcus, Sporolactobacillus, Streptococcus, Tetragenococcus, Vagococcus, and 
Weissella (127). The most well studied of all LAB is the genus Lactobacillus, which is a group of 
facultative anaerobic, fermentative, rod-shaped bacteria, characterized by the ability to ferment 
sugars into lactic acid (127, 128). This specific genera exhibits immense species diversity, with in 
excess of 100 species that are known to occur in various ecological niches, including the human 
GIT, fermented foods and milk (126, 127, 129). Commonly occurring lactobacilli species in the 
GIT include L. acidophilus, L. brevis, L. casei, L. fermentum, L. plantarum, L. reuteri, L. 
rhamnosus and L. salivarius (122, 125, 130).  
 
Lactobacilli can be classified according to their ability to ferment hexose sugars into various 
metabolic end products such as lactic acid, carbon dioxide, ethanol, acetic acid and various other 
minor products. Three fermentation classifications exist; namely obligatory homofermentative, 
facultative heterofermentative and obligatory heterofermentative (126, 129–131). Obligatory 
homofermentative lactobacilli ferment hexose sugars to lactic acid via the Embden-Meyerhof-
Parnas metabolic pathway (126, 129). These LAB are unable to ferment pentoses or gluconate due 
to the lack of the enzyme phosphoketolase (126, 129). Homofermentative pathways yield 1.8 mol 
lactic acid for every 1 mol glucose (129). Facultative heterofermentative LAB utilize the same 
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Embden-Meyerhof-Parnas pathway as obligatory heterofermentative lactobacilli, however the 
presence of inducible aldolases and phosphoketolases allows for the effective fermentation of both 
pentose, hexose sugars and gluconate (126, 129). Lactobacilli exhibiting obligatory 
heterofermentative metabolism, ferment both hexose and pentose sugars utilizing a completely 
different metabolic pathway, namely the phosphogluconate pathway (126, 129). This allows 
obligatory heterofermentative lactobacilli to ferment 1 mol glucose or gluconate to lactic acid, 
carbon dioxide and acetic acid/ethanol in a 1:1:1 ratio (129).   
 
Lactobacillus reuteri and Lactobacillus rhamnosus as probiotics 
 
L. reuteri is obligatory heterofermentative and is predominantly found within the GIT of various 
animals and humans (122, 126, 132). It is considered to be one of the rare lactobacilli that are 
autochthonous inhabitants of the human GIT and other body sites (132). L. reuteri was first isolated 
in the 20th century, but was initially considered to be a L. fermentum sp. until the 1960’s when 
Gerhard Reuter classified L. reuteri as a subspecies of L. fermentum, called L. fermentum Biotype 
II (133). This classification persisted until the 1980’s, when Kandler et al. (134) found that the two 
organisms were in fact distinctive species and subsequently renamed L. fermentum biotype II as 
L. reuteri in honor of Gerhard Reuter.  
 
L. reuteri DSM 17938 is the best studied of all the L. reuteri spp. It was initially isolated from 
Peruvian breast milk in the 1990’s as L. reuteri ATCC 55730, but was later renamed to L. reuteri 
DSM 17938 after two antibiotic resistance plasmids were cured from the strain (135). This allowed 
L. reuteri DSM 17938 to become the first L. reuteri strain applied to human use and it subsequently 
become a popular probiotic supplement (135–137). The origin of this strain is not atypical as recent 
work conducted by Sinkiewicz and Ljunggren (138) found that 50 % of breast milk samples taken 
from women living in rural areas contained L. reuteri, whilst samples originating from urban 
environments had little or no detectable L. reuteri.  
 
L. reuteri strains are often used in probiotic supplements, owing to the health benefits they confer 
on the host. The species is well adapted to the survival and persistence within the human GIT, with 
excellent tolerance to stress induced by the low pH and presence of bile (139–142). Persistence in 
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the GIT has been postulated to be the result of their ability to adhere to both intestinal epithelial 
cells and the mucus layer covering these cells (143–146). The antimicrobial capability of this 
species of lactobacilli is considered to be excellent owing to the production of reuterin, 
reutericyclin, lactic acid and hydrogen peroxide (147–150). The immunological effect of L. reuteri 
strains are well established, with various strains, including DSM 17938, exhibiting anti-
inflammatory effects and aiding in the overall regulation of immune responses within the human 
body (136, 151, 152).   
 
L. rhamnosus is a facultative heterofermentative species and is found in close association with the 
human body (153). While this species is considered to be allochthonous to the human GIT, it is 
still considered to be able to colonize this body system (154–157). The species name L. rhamnosus 
was only suggested by Collins et al. in 1989, since L. rhamnosus was considered to be a subspecies 
of L. casei (L. casei subsp. rhamnosus) up until that point (153). This lack of species delineation 
applied to even the most well-known probiotic, namely L. rhamnosus GG. Lactobacillus 
rhamnosus GG was isolated in 1983 by Sherwood Gorbach and Barry Goldin from healthy human 
gut lumen contents and submitted as L. acidophilus (ATCC 53103) prior to being reassigned to 
the species L. rhamnosus (154–156, 158–160). 
 
Although it is considered to be a transient colonizer of the human GIT, colonic biopsies indicate 
the presence of L. rhamnosus cells even when at or below detectable levels in fecal matter (154, 
156, 157). L. rhamnosus strains have been documented as having superior tolerance to acid 
induced stress conditions and bile salts (154, 155). This may allude to its potential to colonize and 
persist within the GIT, which is further enhanced by the strong adherence of L. rhamnosus strains 
to gut epithelial cells and mucus (156, 157). Probiotic supplements containing L. rhamnosus strains 
have been shown to exhibit immunomodulatory effects, in addition to preventing and alleviating 
antibiotic associated diarrhea and aiding the treatment of allergic reactions (154, 156).  
 
Antimicrobial substances produced by L. rhamnosus strains include lactic acid and hydrogen 
peroxide (154). Although the production of bacteriocins has yet to be detected under standard 
laboratory conditions, it is to be noted that screening of the L. rhamnosus GG genome has revealed 
the presence of numerous bacteriocin-related genes (154).  
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It is well established that use of either L. reuteri or L. rhamnosus independently as probiotic 
supplements confers substantial health benefits to the host (32, 132, 154, 156, 161). The 
established efficacy and safety of these two lactobacilli species make them well suited for this 
purpose. The potential synergistic effect of dual supplementation of these two species of 
lactobacilli has also been documented, with specific emphasis on the use of this combination for 
the treatment and prevention of vulvovaginal candidiasis and urinary tract infections in humans 
(162–164).  
 
1.4. Bacterial Biofilms 
 
Free-living, or planktonic bacterial cells only represent a small fraction of a bacterial population, 
with the majority of cells forming close associations with surfaces to form adherent, sessile 
populations known as biofilms (165, 166). Biofilms are broadly defined as a community of 
microorganisms that assemble at an interface and encase themselves within a protective 
extracellular polymeric substance (EPS) matrix (167). Microbial biofilms are as old as 
microorganisms, although it was not until the 17th century when Anton Von Leeuwenhoek, first 
observed microbial aggregates (biofilms) whilst studying dental plaque (166, 168). The term 
biofilm was first used in the late 1970’s by J.W. (Bill) Costerton, thereby formalizing and naming 
the propensity of all microorganisms to form biofilms on substrata under the appropriate 
environmental conditions (168). The difference between planktonic and sessile cells is exemplified 
by the greater tolerance of bacterial biofilms to deleterious environmental factors, i.e. low pH 
conditions (169, 170). This increased tolerance and tenacious survival ability is best observed and 
understood with respect to antibiotic resistance. Bacterial resistance to antibiotics is greater within 
biofilm-associated bacterial populations than within planktonic populations (169, 170). The 
administration of antibiotic concentrations lethal to planktonic bacterial populations has been 
shown to be sub-lethal to biofilm-associated bacterial cells and this is correlated to a 10 to 100-
fold higher minimum biofilm inhibitory concentration than the corresponding planktonic 
concentration (170). This discrepancy in tolerance and survival has been partially attributed to the 
differential expression of genotypes and subsequent phenotypes between adherent and non-
adherent bacterial populations (165, 166, 169, 171). 
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The phenotypic differentiation between planktonic and sessile populations does not account for 
the existence of a second planktonic phenotype (172). The production and release of planktonic 
cells from sessile biofilms is hypothesized to represent a third phenotype (172). A number of 
authors have confirmed that a distinction between the batch culture-derived planktonic population 
and the biofilm-derived planktonic population exists, with the observation of differences with 
respect to adhesion, antimicrobial susceptibility and virulence (172–175). Therefore, it is of critical 
importance to take the origin of planktonic cells into account. This emphasizes the importance of 
studying microbial populations in a holistic manner, rather than in isolated populations, since 
factors such as survival, virulence and phenotypic changes may be determined by the origin of the 
population in question.  
 
1.4.1. Human GIT-associated Biofilms 
 
The most well characterized biofilms within a human context are those contained in the oral cavity 
(176, 177). These biofilms colonize tooth surfaces and the interfaces between the gums and teeth, 
in the form of dental plaque (178). A fine balance exists between these biofilms and the host; on 
the one hand it forms an integral part of the healthy host’s defense mechanisms, and on the other 
hand it leads to dental caries and periodontitis (177). It is well established that oral biofilms are 
comprised of diverse and complex microbial communities, with a reported diversity in excess of 
800 species (177, 178). 
 
The luminal surface of the human GIT is lined with either a single layer (oral cavity and small 
intestine) or a dual-layer (stomach and colon) of protective mucus as discussed previously (165, 
179). The mucosal layer also provides an adherent surface and creates a distinct microenvironment 
within the larger GIT (169, 180). This microenvironment is important for the formation of biofilms 
within mammalian GIT (181). Bacterial biofilm formation in the mammalian GIT has been studied 
extensively in animals, with only a few studies addressing the presence of biofilms within the 
human GIT (169, 181). Mucosal micro-colony formation has been observed in the GIT of various 
mammals, but the rapid turn-over of the mucus layers may hinder long-term persistence (169, 180). 
However, since the biofilm itself is in a perpetual cycle of detachment and regrowth, it overcomes 
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the hindrance posed by mucus shedding (181). This constant state of biofilm shedding and 
regeneration may therefore account for the survival and persistence of bacteria within the human 
GIT. Recently, Bollinger et al. (181) observed epithelial-associated bacterial biofilms on the 
mucosa of the human appendix. This observation, coupled with the cyclic nature of biofilm 
detachment and regeneration,  led to the postulation that the appendix may serve as a reservoir for 
commensal microorganisms in the human GIT (181). Due to the regular sloughing off of parts of 
the appendix-associated biofilms, the colon is reinoculated with commensal microbes thereby 
facilitating the persistence of these microbes within the human GIT.  
 
The presence of micro-colonies or biofilms within the healthy human GIT has been an area of 
contention in recent years. This is mainly due to the limited number of new fundamental studies 
on the presence or absence of biofilms within the GIT, in contrast to a large number of reviews on 
the subject (76, 166, 169, 180, 182). A large number of reviews on the subject exist, but there is a 
lack of fundamental research on biofilm-associated microbes within the intestines of humans, 
leading to limited understanding of intestinal-associated biofilms (166, 180). As mentioned 
previously (Section 1.2.1), the esophagus and stomach are not considered to be microbial 
reservoirs in healthy humans, since the adverse conditions and rapid transit times through this GIT 
region may limit biofilm formation. Although a healthy esophagus may be sparsely colonized by 
aciduric, Gram positive bacteria, the presence of more extensive micro-colony and biofilm 
formation has been observed in diseased individuals, such as those suffering from Barret’s 
esophagus (180, 183, 184).  
 
Since the microbial composition of the mucosal and fecal microbiota are dissimilar, greater in-
depth investigation of these two communities is critical (166, 180). The intestinal region of the 
GIT consists of complex ecosystems and is a site of intense metabolic activity (165). As previously 
mentioned, the human appendix may serve as a source of inoculum for the colon; this is supported 
by the progressive decrease in biofilm formation from the appendix to the distal end of the colon 
(181). Complex plant-based polymers are degraded in the colon through the synthrophic 
conversion by multispecies biofilms within this region (166). While it is generally accepted that 
biofilms are formed within the healthy intestines, it is thought that more extensive biofilm 
formation occurs in diseased individuals (185).  
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Although the presence of biofilms has been observed within the GIT of diseased individuals, the 
apparent lack of similar observations within healthy humans still remains an unresolved matter. 
(181). Limited progress has been made in the last decade and the overall lack of clarity with respect 
to the definitive absence or presence of biofilms within the human GIT has not allowed for better 
understanding. The significant impact that GIT-associated biofilms may have on the intestinal 
microbiome and host interactions is however recognized and agreed to be critical to our 
understanding of the human gut microbiome (166).  
 
The ability of lactobacilli strains from probiotic supplements or fermented foods to form biofilms 
in vitro has only been assessed in the last decade, with a limited number of studies focused on this 
aspect (156, 186–190). The ability of L. fermentum, L. plantarum, L. reuteri and L. rhamnosus 
strains to form static biofilms on abiotic surfaces to varying degrees has been shown (156, 186, 
187, 189, 190). Despite the fact that these studies have provided critical insight with respect to 
species and moreover, strain variation, among lactobacilli, a notable deficiency is the use of static, 
rather than dynamic flow conditions. The studies fail to take critical environmental conditions into 
account that may influence microbial persistence and propagation. Specific GIT conditions, such 
as flow-induced shear (GI fluids), abrasion-related detachment (digested food), gas and nutrient 
gradients cannot be taken into account using static cultivation techniques (191–194). Therefore, it 
is of critical importance that microbial biofilm studies use static biofilm cultivation as the 
screening tool for which it was intended, followed by continuous-flow biofilm studies to better 
mimic the natural microbial environment.  
 
The essential and complex role of the GIT in human health has, in recent years, been highlighted. 
Probiotic supplementation, although prescribed in an attempt to improve GIT health, remains 
semi-understood, and there is a lack of clarity regarding probiotic interactions with commensal 
microbiota, pathogens and the human host, as well as the role of microbial biofilms in the GIT.  
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1.5. Simulating the Human GIT 
 
The ability to simulate the human GIT is important for various industries, as well as 
pharmaceutical, food and academic research initiatives. The global pharmaceutical industry is 
worth an estimated 1 trillion US dollars as of 2014, with more than 7 000 pharmaceuticals in 
development globally (195, 196). However, less than 12 % of these pharmaceuticals will pass 
clinical trials and be approved by the regulatory bodies (196, 197). This, coupled with the estimated 
pharmaceutical development costs of 500 – 2 000 million dollars, makes it critical to ensure that 
adequate and extensive in vitro studies are done prior to the transition to in vivo studies, involving 
animals and humans (197).  
 
The simulation of the anatomical and physiological parameters within the GIT is complicated 
through the requirement for integrated and coordinated synergism of the multiple tissue and cell 
types. The development of techniques that simulate the GIT can be divided into two distinct model 
systems, which are either static or dynamic in nature. 
 
1.5.1. Static model 
 
The static model for GIT simulation is the oldest, simplest and most widely used model of the GIT 
(198, 199). The static model fundamentally compartmentalizes the GIT into its three main regions; 
the stomach, small intestine and colon (198, 199). This is achieved through individual, closed 
systems each representing one of the three regions. Each system functions independently with 
respect to the others, or as part of a multi-phase system. While multi-phase systems do exist, these 
do not function in a fully integrated and coordinated manner.  
 
The static model allows for the simulation of biochemical parameters within the GIT, at specific 
time points and phases of digestion. The closed nature of this model facilitates reproducibility with 
respect to standardized environmental conditions (198, 199). The simplicity of this model allows 
for rapid experimental set-up and runs, with experimental modifications easily achieved without 
long lead-times or complicated parameter and equipment changes (198, 199). All of these factors 
contribute to this model being cost-effective and easily implemented (198, 199).  
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However, this model is unable to adequately simulate the physiological changes and states that 
exist within the GIT (198, 199). This can be attributed to the lack of peristaltic movement and 
overall flow conditions (i.e. static condition) and the absence of a mucosal barrier, with its 
absorption and secretory functions (198, 199). This, together with the absence of standardized 
protocols and the requirement to adjust the various parameters to suit every objective, renders data 
obtained from this model difficult to compare between experiments and studies (198, 199). 
 
Despite its drawbacks, this model is a critical tool for generating valuable preliminary data prior 
to progressing to more complex models, such as cell lines and complete artificial GIT systems or 
in vivo trials. However, the experimental parameters need to be closely aligned with experimental 
objectives and the physiological parameters under investigation. For example, in acid tolerance 
studies, special focus must be given to maintaining the correct pH parameters. To conclude, a 
thorough understanding of the advantages and limitations of this model is critical for the generation 
of reliable and reproducible data.  
 
1.5.2. Dynamic Model Systems 
 
The GIT is dynamic in nature, with few parameters remaining constant for long periods. Static 
model systems, though useful and indispensable as preliminary or screening tools, are not realistic 
and lack the flexibility required to simulate the dynamic nature of the GIT (200, 201). Dynamic 
model systems allow for the study of potential effects of GIT conditions on food digestion, 
pharmaceuticals and probiotic supplements (200–202). They incorporate the realistic 
physiological parameters of the GIT with the control and reproducibility obtained through 
computer controlled systems (201). Dynamic model systems consist of the following models; 
namely in vitro fermentation models, artificial GIT systems, human cell line models, and in vivo 
GIT studies involving animal models and human trials.  
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In vitro Fermentation Models  
 
In vitro fermentation models are generally used as a substitute for the colonic region of the GIT 
(203, 204). These models rely on the use of single or multiplexed chemostats to simulate the 
fecal/colonic microbiota (203–205). These models have evolved from simple batch systems (static 
model system) to complex systems using continuous flow conditions and narrower parameter 
controls to facilitate the stable cultivation of the colonic microbiota (203, 206). In vitro 
fermentation models circumvent the ethical concerns that arise when conducting microbiota 
studies involving human or animal subjects (203). 
 
This model system allows for the finer regulation of physiochemical parameters through the use 
of complex computational and fluid management systems (206). This finer regulation, coupled 
with the ability to multiplex various chemostats, allows for the simulation of either the average 
colonic environment or of the individual regions of the colon (ascending, transverse and proximal 
colon) within a multiplexed system (203). Planktonic and sessile microbial populations are 
reproducible within these systems. Sessile populations are established through the cultivation of 
microbiota on porous polysaccharide matrixes prior to inoculation of the chemostat (203, 207).  
 
Although in vitro fermentation models are capable of simulating both the planktonic and sessile 
microbial populations within the GIT, the model is limited as it cannot account for transitional and 
compositional changes that occur within the GIT (203, 208). These models furthermore only assess 
microbial functions and not important host functionalities, such as immunological and cellular 
parameters, that are characteristic of the GIT (203, 209). As is the case with the static model 
systems, careful consideration of the experimental objectives is required to ensure that the optimal 
model is used (i.e. single versus multiplex systems), to represent singular or multiple regions of 
the GIT (203, 209).  
 
The functionality of this model extends further than mimicking only the biochemical parameters 
of the GIT, but also simulates the microbial population within the GIT (203, 208, 209). The 
collective attributes of this model system allow for the stable and reproducible cultivation of a 
microbial population ex vivo, thereby facilitating a greater understanding of the interactions 
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between microbial populations, ingested food and pharmaceuticals. Improved insight into these 
interactions may promote a smoother transition from in vitro to in vivo studies and are generally 
accepted on both scientific and ethical grounds.  
 
Artificial GIT Models 
 
To adequately simulate the GIT, a single model is required that will incorporate the movement, 
mixing, absorption and secretory parameters present within the GIT. However, until the early 
1990’s this objective was only partially fulfilled by other models, such as those simulating simple 
gastric functions (210). The advent of an artificial GIT model by Minekus et al. allowed for the 
most realistic simulation of the monogastric human GIT to date (211). The system allowed for 
GIT-relevant physiological parameters such as pH, bile concentration and enzymatic actions to be 
matched ex vivo with a high degree of accuracy and reproducibility (201, 212). These artificial 
systems are based on computer-controlled simulation using in vivo data to direct a multi-
compartmental system consisting of a series of peristaltic valve pumps, membranes, filters, pH 
and temperature sensors (201, 211).  
 
The ability to simulate the luminal enzymatic, absorption and secretion parameters within these 
models allows for better in vitro-in vivo correlation and predictions (201, 212). It promotes a better 
understanding of food, pharmaceutical and nutraceutical behavior and efficacy within the human 
GIT, prior to the transition to in vivo trials (211), and is, therefore, cost effective and minimizes 
ethical considerations.  
 
Despite achieving good reproducibility and in vitro-in vivo correlations, factors such as host 
functions are only partially accounted for through the removal and secretion of metabolites and 
enzymes, whereas mucosal parameters are not assessed due to their complexity (201, 213, 214). 
Other host functions, such as induced inflammatory responses (immunological) or cellular 
interactions (cross-talk between cells) are not assessed, leaving a deficiency in the complete 
simulation of digestion. The complexity of these models means that specialized training and 
equipment is required for successful use of these systems (201, 211, 213).  
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Artificial GIT models provide scientists and industries with a powerful tool for understanding the 
interaction between exogenous substances and the GIT, and provide the most accurate, though 
incomplete, systems for simulating the human GIT in vitro.  
 
Human Cell Line Models 
 
The use of human cell lines as a proxy for human body systems has allowed a greater depth of 
understanding with respect to human health and disease states. In the 65 years since the first human 
cell line was isolated and used (HeLa cells in 1953), their availability has increased to close to 
4,000 cell lines, maintained by the American Type Culture Collection repository (215, 216). 
Human cell lines circumvent many ethical concerns associated with human and animal trials, in 
addition to mitigating inter-individual variations, which provide a distinct variable in human and 
animal studies (217). Human cell line models are generally characterized by a monolayer of viable, 
polarized and fully differentiated cell types and can be co-cultured with other monolayer cell lines 
to produce more complex systems, such as combining two intestinal epithelial cell lines with 
different functions (i.e. Caco-2 and HT29-MTX cells) (218, 219).  
 
Due to the clonal nature of cell lines, these models allow for consistency and reproducibility 
between experiments (203, 220). These models successfully simulate mucosal surfaces and have 
allowed researchers to elucidate the mechanistic, immunological and physiological effects of food, 
pharmaceutical, nutraceutical and toxic compounds (220–223). The use of living cells not only 
provides greater insight into the potential cytotoxicity (concentration required to be cytotoxic) of 
compounds, but also allows the effect of these compounds to be assessed in real time as it would 
occur within the human body (223). 
 
The vast number and variation in cell lines leads to a large number of models, which necessitates 
the careful selection of specific models and cell lines in accordance with experimental objectives 
(203). A reductionist approach is practiced within cell culturing research, whereby complex body 
systems or tissues are reduced to mono- or bi-layers of cells (220, 224). The physiological 
complexity observed in vivo is lacking, and although advances have been made with respect to 
complex in vitro models, in vivo models cannot be replaced completely by current cell line models 
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(203). The process of eukaryotic cell culturing furthermore strongly relies on the maintenance of 
aseptic conditions, since cell lines are prone to microbial contamination (217, 219, 224).  
 
Human cell line models provide valuable insight into the immunological and cellular responses 
that human tissues might experience when subjected to certain conditions or compounds. The 
requirement for specialized equipment and strict aseptic techniques limit the feasibility of some 
studies. The limited complexity of current models may also restrict the types of studies conducted 
or may not provide complete insight into effects on tissues consisting of multiple cell types.  
 
In vivo GIT model systems 
 
In vivo model systems provide the most realistic simulation of the human GIT, with all its 
complexity and functions. Since the anatomical and physiological structures and processes are 
functionally incorporated in these systems, these models are capable of achieving that which other 
models cannot, namely the simulation of all host functions. As a result, these models are powerful 
tools to elucidate effects and functions within the GIT.  
 
In vivo Animal Models 
 
Animal models, although not identical to the human body, provide a significantly better analog to 
the human body than the model systems previously discussed. The processes of digestion and 
absorption within specific, monogastric animal models are similar to those in the human GIT (225, 
226). The presence of both luminal and mucosal surfaces allows for a more holistic scenario, rather 
than the simulation of either one or the other surface as seen in other models (227).  
 
Animal models have often been used in place of human subjects, since there are fewer ethical 
considerations that need to be taken into account (227). The sample size and by default the 
statistical power is dramatically increased when using animal models compared with human 
subjects (227). This, in conjunction with decreased inter-individual variation within animal 
models, provides a better representative sample of effects or response within a broader population 
(227). Both the adaptive and innate immunological responses are better studied using animal 
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models than human cell lines (225, 227). Owing to the moderate to high degree of similarity 
between the human GIT and that of other mammals (pigs, rodents and non-human primates), 
animal models allow reasonable predictions to be made regarding the interaction between 
compounds and the human GIT (226, 227).  
 
Although animal models provide great insight into GIT functionality (absorption and secretion) 
and responses (immune) due to exogenous compounds, limitations do exist. Despite the anatomical 
and physiological homology that exists between human and other mammalian GIT systems, there 
is also a large degree of variation. These include variations in food transit times, digestive enzyme 
composition and concentrations, as well as metabolism, and therefore animal trials can never fully 
replace human trials (225–227). Since each model has its own advantages and limitations, careful 
matching of the model with the experimental objectives prior to starting the trial, in addition to 
scrutinizing the experimental outcome, is required (226, 227). The other limitations that these 
models suffer from is the high cost required to establish and maintain specialized handling 
facilities for the animals (226, 227), and the ethical concerns involving animal experimentation. 
 
Even though no single animal model is a perfectly complete analog for human subjects, these 
models do provide a “perfectly-imperfect” system for the vital screening and evaluation of 
objectives prior to transitioning into human trials, which may ensure better performance in and 
successful transitioning through human trial phases.  
 
Human Trials 
 
The culmination of all medical research is the transition from proxy models into human studies. 
Human trials provide the final and often most critical data pertaining to scientific research (228). 
The first semi-formalized human trial, was conducted in 1747 by Dr James Lind pertaining to 
scurvy (228, 229). Human trials have evolved significantly in the last 250 years, with most of the 
progress occurring in the last 100 years. The first randomized controlled human trial involving 
streptomycin was only conducted half-way through the 20th century (1947), and since that time 
human trials have become a completely standardized procedure (229). The use of human subjects 
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has provided the medical and scientific communities with great insights into the effects of food, 
pharmaceuticals and microorganisms on the human body and GIT specifically.   
 
The use of human subjects is inevitably the only way of determining effects, influences and 
interactions within the human body. The generation of “real-world” safety and efficiency data is 
critical for the generation of knowledge and development of new compounds (228). The ability of 
human trials to examine any potential adverse effects that the introduction of an exogenous 
substance or organism may have, make them a powerful and indispensable tool (228). 
 
The complexity of the human body and inter-individual variability has a dramatic effect on the 
outcomes of human trials, which is further complicated by the selection criteria of the study (228). 
The selection criteria are often stringent and thus select for a sub-population of individuals which 
fit these criteria (228). This complicates the extrapolation of trial outcomes to the broader 
population. Human trials are lengthy and the time lapse from the start of a clinical trial to approval 
by regulatory bodies can span years. The ethical considerations supporting these types of studies 
further restrict the types of objectives that can be examined (230), and as a result these trials are 
limited to cause-and-effect studies of dietary components, lifestyle preferences and pharmaceutical 
interventions (230, 231).  
 
Human trials have over the course of the last century fundamentally shaped our outlook and 
understanding of the human body and interactions within it. Invaluable information has been 
garnered with respect to our understanding of human metabolism, immunological functionality, 
pathogenesis and human-microbial interactions (228, 230, 231). The use of randomized, controlled 
studies has become the gold standard in understanding the causality between dietary, lifestyle, 
medical and pharmaceutical interventions in a human context (228, 232).   
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1.5.3. Simulated Gastrointestinal Fluids 
 
The complexity and ethical considerations behind the use of in vivo models, makes the use of in 
vitro GIT models more common and easier to implement. However, the use of non-in vivo models 
requires special focus on the fluids used to simulate gastrointestinal (GI) fluids (40). GI fluids can 
be separated into four major, compositionally distinct fluids; saliva, gastric fluid, small intestinal 
fluid and colonic fluid. In order for correlations to be made between in vitro and in vivo studies, 
the fluids used to simulate GI conditions need to be biologically relevant, such as those available 
from Biorelevant Media, which was founded on research into the development of biologically 
appropriate simulated GI fluids. The standardization and commercial availability of these 
simulated gastric fluids have allowed for greater experimental reproducibility and better 
physiological correlation.  
 
Biorelevant media are a varied group of fluids that seek to realistically simulate GI conditions, 
based on ever-evolving physiological data (233, 234). These media are used during early stages of 
drug discovery and development, to provide better understanding of effects GI fluids may have on 
these compounds and allow for better in vitro-in vivo correlations, which may reduce the number 
of animal of human subjects required during in vivo trials (233).   
 
The human GI system is made more complex through the presence of two distinct physiological 
states; namely fed- and fasting-state (40, 233, 234). At any given time, the stomach and small 
intestine are considered to be in one of these two states, whilst the oral cavity and colonic regions 
have temporal fluctuations, lacking distinct fed- and fasting-states (40, 233).  
 
The biorelevant media differ with respect to three main factors; pH, osmolarity (electrolyte 
concentration) and enzymatic composition. The composition of the four biorelevant media will be 
discussed in brief, in view of the use of simulated fasting-state GI fluids in Chapter 3.  
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Simulated Saliva 
 
Human saliva is difficult to simulate owing to its complex composition and exogenous effects of 
diet, fluid intake and so forth (40, 235). The pH of saliva is critical for the functioning of the lingual 
lipases and salivary amylases, and is therefore maintained in the range of 5.3 to 7.8 by bicarbonate 
ions (40, 235). No standardized or recommended composition for simulated saliva exists, and 
various formulations with distinct buffer composition are available (40, 236).  
 
Simulated Gastric Fluid 
 
The ability to simulate gastric fluid is critical to the pharmaceutical industry and medical sciences. 
Simple aqueous buffers lack the ability to appropriately represent the physiological parameters of 
gastric fluid (77). Various attempts have been made to formulate and standardize the composition 
of both fed- and fasting-state gastric fluids, many of which have used synthetic surfactants and 
components, in addition to lower concentrations of components than that present at normal 
physiological states (233, 237, 238). The emphasis of functional biorelevance over mere 
compositional biorelevance (239) led to the development of a biorelevant gastric medium, a term 
coined by Vertzoni et al. in 2005, which realistically represented both fed- and fasting-states (238). 
The physiological accuracy of this biorelevant medium is evident by the lack of major differences 
between gastric aspirate and the simulated gastric fluid (77).  
 
Fasting-State Gastric Fluid 
 
The composition of fasting-state simulated gastric fluids (FaSSGFs) generally involves a sodium 
buffer combined with surfactants, with a pH ranging from 1.2 to 2.0 (40, 233, 238). The first 
FaSSGFs made use of synthetic or non-physiological surfactants such as triton-X or sodium lauryl 
sulfate in order to reduce surface tension (233, 240). However, significant inconsistencies in 
composition occurred due to instability as a result of the hydrolysis of sodium lauryl sulfate at pH 
values lower than 4 (233). Obtaining the correct physiological surface tension with the use of 
natural/biorelevant surfactants was achieved by Vertzoni et al. (238). Replacing triton-X and 
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sodium lauryl sulfate with physiologically concentrations of bile and lecithin allowed for good 
correlation between FaSSGF and fasting-state fluids obtained during human studies (77, 233, 238).  
 
Fed-State Gastric Fluid 
 
Simulating a fed-state gastric fluid is not as easily achieved, since the dynamic and heterogeneous 
compositional changes in the fed stomach over time need to be considered (40, 233). 
Homogenized, long-life milk has been used in dissolution media, due to a similar 
carbohydrate:fat:protein ratio to the stomach contents of fed, healthy individuals (40, 233). The 
changing intragastric composition that occurs during fed-state can be simulated by using 
“snapshot” media which simulate early, middle and late fed-state phases (40, 233). Each phase 
differs with respect to buffer composition, buffer to milk ratio and pH. The middle phase is 
considered to be representative of the entire process and has led to the development of a 
representative fed-state simulated gastric fluid (FeSSGF) (40, 238).  
 
Simulated Small Intestinal Fluid 
 
Small intestinal fluid is mainly comprised of water, pancreatic enzymes, bile and mucus (67). For 
many years simple Simulated Intestinal Fluid (SIF) was used, consisting of a phosphate buffer and 
pancreatin at a pH of 6.8 (241). However, as in the case of the first simulated gastric fluids, this 
simple buffered solution did not accurately represent the physiological conditions due to a lack of 
natural surfactants (233, 240). The subsequent addition of bile salts and phospholipids achieved a 
biologically relevant surface tension (240). Similar to the stomach, the small intestine has a fed- 
and fasting-state, which both need to be simulated in order to fully represent conditions within this 
environment.  
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Simulated Fasting-State Small Intestinal Fluid 
 
The original Fasting-State Simulated Intestinal Fluid (FaSSIF) developed by Dressman et al. (240) 
in the late 1990’s was based on a phosphate buffer, similar to the original SIF (240, 241). The 
addition of sodium taurocholate and lecithin to the buffer took into consideration the solubilizing 
ability of small intestinal fluids (233). The pH of FaSSIF is slightly lower than that of SIF (pH 6.5 
versus 6.8). The composition of FaSSIF was recently modified based on additional physiological 
data obtained from human trials (40, 77, 233). These minor changes included the reduction of 
lecithin concentration (0.75 mM to 0.2 mM), changes in buffer species from phosphate to maleate 
buffer, and changes in osmolarity (77). The modifications to FaSSIF to produce FaSSIF-V2 has 
further standardized and contributed to a reproducible and physiologically relevant media (77, 233, 
240). 
 
Simulated Fed-State Small Intestinal Fluid 
 
The development of Fed-State Simulated Intestinal Fluid (FeSSIF) occurred concurrently with that 
of FaSSIF, with the major difference being the higher concentration of sodium taurocholate and 
phospholipids (4:1 ratio maintained), with an accompanying decrease in pH to 5.0 from 6.5 (233, 
240). The buffer capacity and osmolarity of FeSSIF were also adjusted to physiologically relevant 
conditions. As with FaSSIF, Jantratid et al. (77) revisited the composition and physiological 
relevance of FeSSIF, since it was determined that the pH in the duodenum and jejunum decreased 
slowly. This lead to the development of a “snapshot” media as with FeSSGF, which took into 
account the gradual changes in pH, bile and lipid composition within the small intestine (77). 
Glyceryl monooleate and sodium oleate (lipolysis products) were incorporated into the updated 
media. FeSSIF-V2 is representative of postprandial conditions within the small intestine (233). 
The development and use of a single “snapshot” medium for the simulation of fed-state in the 
small intestine, has eliminated the need for three separate formulations and allowed for better 
standardization. 
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Simulated Colonic Fluid 
 
Colonic fluid is mainly comprised of water, electrolytes and short-chain fatty acids (67). Two basic 
media formulations were developed to simulate colonic fluid (SCoF1 and SCoF2); the first made 
use of a phosphate buffer adjusted to pH 7, while the latter consisted of an acetate buffer with a 
significantly lower pH of 5.8 (40, 233). SCoF1 and SCoF2 simulate the colonic environment as a 
complete system and do not discriminate between the three regions of the colon or between fed- 
and fasting-states. The development of fed- and fasting-state colonic fluids was only achieved in 
2010 (40, 242).  
 
Fasting-State Colonic Fluid 
 
Vertzoni et al. (242) developed a physiologically relevant fasting-state colonic fluid that simulates 
the fluid composition of the ascending colon (242). Fasting-State Simulated Colonic Fluid 
(FaSSCoF) replaced the acetate and phosphate buffers with a Tris/maleate buffer with a final pH 
of approximately 7.8 (40, 242). The major difference between FaSSCoF and both SCoF1 and 
SCoF2 is the presence of bile salts, phospholipids and short-chain fatty acids in FaSSCoF (40, 
242).  
 
Fed-State Colonic Fluid 
 
While the Fed-State Simulated Colonic Fluid (FeSSCoF) utilizes the same buffer as FaSSCoF, it 
has a lower osmolarity as well as a significantly lower pH (6.0 versus 7.8) (40, 242). In addition, 
it contains a four-fold higher bile salt concentration in conjunction with an approximate doubling 
in phospholipid and short-chain fatty acid concentrations (40, 242). 
 
The relatively recent introduction of simulated fed- and fasting-state colonic fluids has brought in 
vitro experimental conditions slightly closer to conditions present in the human colon. However, 
the presence of a large microbial population within the colon may potentially alter the colonic fluid 
composition through metabolite production, thus additional developments are required to improve 
simulated colonic fluids.   
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The need for biologically relevant GI media as a surrogate for GI fluids obtained from human 
subjects is critical for the pharmaceutical and medical research industries. The ethical and cost-
effective advantages of in vitro testing using appropriate simulated gastric fluids incentivizes the 
continued development and refinement of these systems and fluids. Each improvement with 
respect to better simulation of the in vivo physiological conditions allows for better prediction of 
in vivo performance of pharmaceuticals and nutraceuticals. 
 
Researchers and commercial probiotic manufacturers assume that their strains and formulations 
persist within the human GIT, however as previous stated probiotic supplementation is thought to 
be only a transient process. However, since research conducted on probiotic supplementations only 
examine planktonic populations and ignore the sessile populations. Therefore, the need to 
experimental assess survival of sessile populations of probiotics under the prevailing conditions 
within the human GIT are required to complete the scientific knowledge behind probiotic 
supplementation. To circumvent the ethical considerations required in obtaining human 
gastrointestinal fluids, simulated fasting-state gastrointestinal fluids need to be utilized to 
realistically mimic the harsh environmental conditions that are prevalent in the human GIT (pH 
changes, bile and enzymatic damage). The use biologically relevant fluids could facilitate the 
investigation of the in vitro survival response of both planktonic and sessile populations of bacteria 
following exposure to GIT-relevant conditions.  
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CHAPTER 2: Lactobacillus rhamnosus HFI-K2 and Lactobacillus reuteri 
HFI-LD5, isolated from human feces, exhibit promising adhesion 
characteristics 
 
2.1. Abstract 
 
Lactobacillus reuteri HFI-LD5 and Lactobacillus rhamnosus HFI-K2, isolated from human feces, 
formed biofilms on hydrophobic abiotic surfaces. The two strains displayed different cell surface 
properties, with L. rhamnosus HFI-K2 having a significantly higher electron donating or basic 
surface, in addition to a higher degree of cell surface hydrophobicity. Neither of the two strains 
possesing in vitro mucinolytic activity. Furthermore, no atypical antibiotic resistance was observed 
for either strain. The survival of both isolates following exposure to acidic conditions (pH 2.5) and 
bile salt stress (0.5% and 1.0% w/v), the ability to adhere, may contribute to persistence of these 
strains within the human GIT. The significantly higher surface hydrophobicity of L. rhamnosus 
HFI-K2, compared to L. reuteri HFI-LD5 (37.71 % vs 8.82 %, p ˂ 0.05), more extensive in vitro 
biofilm formation by L. rhamnosus HFI-K2, is especially promising with regards to potential 
application as a probiotic. 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 69 
2.2. Introduction 
 
The gastrointestinal tract (GIT) is one of the most heavily colonized organs within the human 
body, with an estimated 70 % of microorganisms residing in the colon (1). The Human Gut 
Microbiota (HGM) plays a significant role in human development, nutrition and physiology (1) 
and is often referred to as a “virtual organ within an organ” (2). Continuous use of antibiotics, 
long-term drug treatments, chemotherapy, abnormal stress and sudden changes in hormone levels 
are a few of the causes leading to an imbalanced HGM and, ultimately, a dysfunctional GIT (2). 
 
The use of probiotics to ameliorate gut dysfunction and maintain gut homeostasis is the corner 
stone of the probiotic field. Probiotic bacteria may regulate gut dysfunction through the production 
of metabolic compounds such as antimicrobial peptides, organic acids and hydrogen peroxide (3). 
This may reduce enteric pathogen levels and alleviate antibiotic-associated diarrhea. Recent 
developments have, however, revealed that probiotics may also exert a larger systemic effect on 
the host by regulating immunomodulation, nutrition, metabolism and providing an overall 
maintenance of gut homeostasis. 
 
A probiotic is defined as an organism that is resistant to bile salts, susceptible to antibiotics, lacks 
pathogenicity, is able to adhere to cell surfaces and modulate the immune system, while eliciting 
positive health benefits (4). The selection of probiotic microorganisms is based on fulfilling these 
criteria. Probiotic supplements are dominated by species from the two genera Lactobacillus and 
Bifidobacterium, with both genera having been awarded GRAS status (5, 6). Lactobacilli are 
estimated to comprise 7 % of the total HGM (7) and members of this genus are considered to be 
both autochthonous (L. gasseri, L. mucosae, L. salivarius and L. reuteri) (8, 9) and allochthonous 
(L. acidophilus, L. fermentum, L. plantarum and L. rhamnosus) (9) to the GIT. 
 
Few lactobacilli spp. are considered to be autochthonous to the human body and specifically the 
human GIT (10), except for L. reuteri spp. which are not only able to colonize the human GIT but 
also persist within this harsh environment (10, 11). This species of lactobacilli has been shown to 
adhere to both mucin and epithelial cells, whilst also being able to form biofilms within the GIT 
of some animals (11–13).  
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Although L. rhamnosus spp. are considered to be transient colonizers of the GIT, numerous studies 
focused on L. rhamnosus GG have provided evidence for its successful survival and persistence 
within the human GIT (14–18). L. rhamnosus GG has shown excellent in vitro and in vivo 
adherence to epithelial cells and mucus, thus providing an explanation for its persistence for weeks 
after cessation of supplementation (19). This however fails to take into account potential biofilm 
formation, which may better explain persistence within the human GIT (20).  
Therefore the potential for successful GIT survival and colonization should be evaluated on a case-
by-case basis, rather than basing it on species classification. This study therefore aimed to compare 
two novel Lactobacillus spp. isolated from healthy human GIT and classified as L. reuteri and L. 
rhamnosus, with respect to classical/ideal probiotic criteria as well as biofilm formation abilities. 
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2.3. Materials and Methods 
 
2.3.1. Isolation of bacteria 
 
Fecal samples of healthy individuals were homogenized in sterile maximum recovery diluent 
(MRD, Oxoid Ltd., Basingstoke, Hampshire, UK) and serially diluted. Dilutions were plated onto 
MRS Agar (Biolab, Biolab Diagnostics, Midrand, SA), supplemented with 1.0 % (w/v) bile salts 
(Oxoid), 0.25 % (w/v) CaCO3 and 0.1 % (w/v) cycloheximide (Sigma-Aldrich, St. Louis, MO, 
USA). Acid production, observed as colonies with clear halos, were streaked to purity on MRS 
Agar (Biolab).  Plates were incubated at 37°C for 48 h. Two reference strains, Lactobacillus reuteri 
DSM 17938 and Lactobacillus rhamnosus R11, were isolated from commercially available 
probiotic supplements and cultured at 37°C on MRS Agar (Biolab).  
 
2.3.2. Growth at low pH 
 
Acid-producing isolates were streaked onto MRS agar, prepared by adding 1.0 % (w/v) Phytagel 
(Sigma-Aldrich) to MRS Broth (Biolab) that had been adjusted to pH 2.5 and 3.0, respectively, 
with 1 M HCl. The medium was sterilized by autoclaving. Plates were incubated at 37°C for 48 h. 
 
2.3.3. Hemolytic- and mucinolytic activity 
 
Colonies selected from MRS Phytagel plates were streaked onto blood agar plates (National Health 
Laboratory, Cape Town, South Africa) and incubated at 37°C for 48 h. Isolates with no hemolytic 
activity (no clear zones surrounding the colonies) were selected and streaked onto Plantarum 
Minimal Medium 5 (21), supplemented with either 1.0 % (w/v) glucose or 0.5 % (w/v) mucin.  
Both media were solidified by adding 1.8 % (w/v) agarose. Mucin from porcine stomach (type II, 
Sigma-Aldrich) was purified according to the method of Zhou et al. (22) and lyophilized. All plates 
were incubated at 37°C for 72 to 96 h and then flooded with 0.1 % (w/v) amido black (Sigma-
Aldrich), dissolved in 3.5 M acetic acid. After 30 min, the plates were destained with 1.2 M acetic 
acid. The hydrolysis of mucin was observed as clear zones surrounding  the colonies.  
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2.3.4. Identification of isolates 
 
Selected isolates were Gram-stained and tested for catalase activity by covering 24 h-old colonies 
on MRS Agar (Biolab) plates with 5 % (v/v) H2O2. Genomic DNA was extracted from each of the 
isolates by using the ZR Fungal/Bacterial DNA MiniPrep™ kit (Zymo Research Corporation, 
Irvine, CA, U.S.A.), according to the manufacturer’s instructions. The 16S rRNA gene was 
amplified using primers 8F: (5’-CAC GGA TCC AGA CTT TGA TYM TGG CTC AG-3’) and 
1512R: (5’-GTG AAG CTT ACG GYT AGC TTG TTA CGA CTT-3’) and Q5 High-fidelity DNA 
polymerase (Inqaba Biotechnical Industries, Pretoria, South Africa). The following thermal 
cycling conditions were used: Initial denaturing at 98°C for 1 min, followed by 30 cycles of 
denaturing (98°C for 10 s), annealing (58°C for 30 s) and elongation (72°C for 1 min), with a final 
elongation step at 72°C for 2 min. The recombinase A gene (recA) was amplified using primers 
AmpF:(5’-GCC CTA AAA AAR ATY GAA AAG AAH TTY GGT AAA GG-3’) and AmpR; 
(5’-AAT GGT GGC GCY ACY TTG TTT TTH ACA ACT TT-3’) and Q5 High-fidelity DNA 
polymerase (Inqaba Biotechnical Industries). Initial denaturing was at 98°C for 5 min, followed 
by 35 cycles of denaturing (98°C for 1 min), annealing (55°C for 30 s), elongation (72°C for 1 
min) and a final elongation step at 72°C for 2 min. Amplicons were analyzed by electrophoresis 
on an agarose gel (0.8 % w/v) stained with ethidium bromide.  DNA fragments corresponding to 
the size of 16S rRNA and recA were recovered from the gel and purified using the QIAquick PCR 
purification kit (Qiagen). DNA fragments were cloned using the CloneJET PCR cloning kit® 
(Inqaba Biotechnical Industries) and sequenced. Sequences were checked using Vector NTI 
Advanced 11.0 (Invitrogen, Carlsbad, CA) and compared with known sequences in GenBank 
(National Center for Biotechnology Information).  Sequence alignment was done using the basic 
local alignment search tool (BLAST; http://blast.ncbi.nlm.nih.gov.ez.sun.ac.za/Blast.cgi).  
 
2.3.5. Antibiotic susceptibility 
 
Antibiotic susceptibility was assessed using the disk diffusion method, according to the British 
Society for Antimicrobial Chemotherapy (23). Paper disks, impregnated with antibiotics, were 
placed onto Mueller Hinton agar (Oxoid) plates, each seeded with 500 µl (108 CFU.ml-1) of the 
test strain. Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 2592 served as 
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controls. The antibiotics tested were Trimethoprim (1.25 µg), Sulfamethoxazole (100 µg), 
Sulfamethoxazole-Trimethoprim (25 µg), Sulphonamides compound (300 µg), Oxacillin (1 µg), 
Methicillin (25 µg), Dicloxacillin (25 µg), Gentamicin (10 µg), Tetracycline (30 µg), Kanamycin 
(30 µg), Nitrofurantoin (300 µg), Ampicillin (10 µg), Meropenem (10 µg), Penicillin (10 µg), 
Rifampicin (5 µg), Tobramycin (10 µg), Chloramphenicol (30 µg) and Clindamycin (2 µg). Plates 
were incubated for 24 to 48 h at 37°C and the diameter of inhibition zones measured. Susceptibility 
was recorded based on guidelines of the Clinical and Laboratory Standards Institute (24). 
 
2.3.6. Microbial adhesion to solvents (MATS) and auto-aggregation properties 
 
Non-hemolytic isolates that were resistant to 1.0% (w/v) bile, able to grow at pH 2.5 and unable 
to hydrolyze mucin, were selected for further studies.  Cell surface properties of the strains were 
studied by determining their Lewis acid-base properties, according to the microbial adhesion to 
solvents (MATS) test used by Bellon-Fontaine et al. (25). In short, isolates were cultured in MRS 
Broth (Biolab) for 18 h at 37°C, harvested (2000 x g, 10 min, 4°C), washed twice with sterile 
phosphate buffered saline (PBS, pH 7.2) and resuspended in sterile PBS to an optical density 
(OD600nm) of 0.70 ± 0.05 (A0 at t=0). Suspended cells (4.25 ml) were added to 750 µl chloroform 
(acidic monopolar solvent), and in a separate experiment to hexadecane (non-polar solvent). The 
experiments were repeated, but with ethyl acetate (basic monopolar solvent) and decane (non-polar 
solvent). All chemicals were of the highest purity and from Sigma-Aldrich. Cell suspensions were 
vortexed for 90 s and then stored at 37°C for 15 min to allow separation of the two phases. From 
each of the cell suspensions, 1 ml of the aqueous phase was carefully removed and optical density 
determined at OD600nm. The percentage adherence (affinity of cells for non-polar and monopolar 
solvents) was calculated using the following equation: 
 
Percentage adherence =  [1 − (
𝐴𝐹
𝐴0
)  𝑋 100] 
Where A0 represents the initial absorbance (t = 0) and AF the absorbance after 15 min.  
 
Auto-aggregation properties of the isolates were determined according to the method described by 
Kos et al. (26), with a few modifications. The isolates were each cultured in MRS Broth (Biolab) 
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at 37°C for 18 h, harvested (2 000 x g, 10 min, 4°C), washed twice with sterile PBS (pH 7.2) and 
resuspended in sterile PBS to an OD600nm of 0.50 ± 0.05 (A0 at t=0). Fifteen milliliters of the cell 
suspension were transferred to sterile test tubes and incubated at 37°C for a further 20, 60, 180, 
360 and 720 min. At each of these time points, 1 ml of the upper part of the cell suspension was 
transferred to a disposable cuvette and the OD600nm reading recorded (At at each time point). The 
percentage auto-aggregation was determined as follows:  
 
Percentage auto − aggregation = [1 − (
𝐴𝑡
𝐴0
)]  𝑋 100 
 
Where A0 represents the initial absorbance (t = 0) and At the absorbance readings recorded at each 
of the time points. 
 
2.3.7. Screening for bacteriocin production 
 
Strains that adhered to polar solvents (chloroform or ethyl acetate) and with auto-aggregation 
properties were inoculated into MRS Broth (Biolab) and incubated at 37°C for 24 h. Cells were 
then harvested (15 000 x g, 10 min, 4°C), the cell-free supernatant of each strain adjusted to pH 
6.5-7.5 with 1 M NaOH and heated at 80°C for 10 min to kill viable cells. The agar well-diffusion 
method of Tagg and McGiven (27) was used to test for bacteriocin activity. Twenty milliliters of 
MRS Agar (Biolab) was inoculated with 200 µl (108 CFU.ml-1) Lactobacillus sakei LMG 13558 
(received from Laboratorium voor Microbiologie, University of Ghent, Ghent, Belgium). Another 
plate, prepared with 20 ml of Listeria Enrichment Agar (Oxoid), was inoculated with 200 µl (108 
CFU.ml-1) Listeria monocytogenes EGD-e (received from Colin Hill, University College Cork, 
Cork, Ireland). The agar concentration in both plates was 0.8 %, w/v).  Wells prepared in the agar 
were filled with 50 µl of the heat-inactivated cell-free supernatant. Plates seeded with L. sakei were 
incubated at 30°C and those seeded with L. monocytogenes at 37°C for 24-48 h. 
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2.3.8. In vitro biofilm assay 
 
Biofilm formation was assayed according to Lebeer et al. (19), with minor modifications. Strains 
were inoculated into the following growth media, undiluted and 1:10 diluted:  MRS Broth (Biolab), 
modified MRS (mMRS) with glucose replaced by 20 g.l-1 gluconate, and modified Tryptone Soy 
Broth (mTSB) consisting of 15 g.l-1 TSB (Biolab) enriched with 20 g.l-1 peptone from meat 
(Sigma-Aldrich). All growth media were adjusted to pH 6.5 with HCl before autoclaving. 
Incubation was at 37 °C for 18 h.  Cells were harvested (2 000 x g, 4 °C, 10 min) and resuspended 
to 108 CFU.ml-1 in the respective growth media (undiluted and diluted). Two-hundred microliters 
of each cell suspension was transferred to wells in a 96-well U-shaped polystyrene microtiter plate 
(Greiner Bio-One GmbH, Kremsmünster, Austria). Cells of L. reuteri DSM 17938 and L. 
rhamnosus R-11, prepared in the same way, served as controls. All plates were incubated at 37 °C 
for 72 h, without shaking. Wells were washed three times with sterile PBS to remove loosely 
adhered cells. Adhered cells were stained for 30 min at 25˚C with 200 µl 0.1 % (w/v) crystal violet, 
dissolved in isopropanol:methanol:PBS (1:1:18 v/v). Excess staining solution was aspirated and 
the wells rinsed three times with distilled water. The rinsed plates were air-dried for 30 min and 
the adherent dye solubilized through the addition of 200 µl 30 % (v/v) glacial acetic acid (Sigma-
Aldrich). After 15 min, 125 µl of each suspension was transferred to clean wells of a 96-well flat 
bottom polystyrene microtiter plate and absorbance measured at 595 nm using xMarkTM (Bio-Rad). 
Nine biological replicates in two independent experiments were performed for each of the strains 
or set of conditions. Readings were presented as means ± standard deviation. Sterile medium was 
used as negative control.  
 
2.3.9. Statistical analyses 
 
All experiments were conducted in triplicate. Results of growth under bile stress, auto-aggregation 
and MATS are expressed as the mean and standard deviation of three independent experiments. 
One-way ANOVA, followed by Tukey’s post-test was used to determine statistically significant 
differences. P values < 0.05 were considered significant. Pearson Correlation analysis was 
conducted for auto-aggregation versus hydrophobicity with statistical significance determined at 
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p ˂ 0.05. Statistical analysis was performed on the data using SPSS 22.0 (IBM, SPSS, Chicago, 
Ill., U.S.A.). 
 
2.4. Results 
 
Nine Gram-positive, catalase negative, acid-producing strains were isolated from feces. Five of 
these isolates tested positive for alpha hemolytic activity and were excluded from further analysis. 
None of the remaining four isolates hydrolyzed mucin (results not shown). Three of the four 
isolates had identical 16S rDNA and recA sequences and displayed greater than 98% DNA 
homology with both genes of L. reuteri DSM 20016 (NR 075036 and CP000705.1 respectively). 
Isolate HFI-LD5 was selected as the most representative. Isolate HFI-K2 shared greater than 98% 
16S rDNA and recA sequence homology with L. rhamnosus JCM 1136 (NR_043408.1) and L. 
rhamnosus GG (FM179322.1) respectively. Nucleotide sequences of the 16s rRNA and recA genes 
of the two isolates were deposited in the NCBI Nucleotide database 
(http://www.ncbi.nlm.nih.gov/nuccore/) 16S rDNA and recA sequences for L. reuteri HFI-LD5 
(KT803960 and KT803962) and L. rhamnosus HFI-K2 (KT803961 and KT803963) respectively.  
 
L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 were resistant to Trimethoprim (1.25 µg), 
Sulfamethoxazole (100 µg), Sulfamethoxazole-Trimethoprim (25 µg), Sulphonamides compound 
(300 µg), Oxacillin (1 µg), Methicillin (25 µg), Dicloxacillin (25 µg) and Gentamycin (10 µg).  L. 
rhamnosus HFI-K2 displayed intermediate resistance to Tetracycline.  The reference strain, L. 
rhamnosus R-11, on the other hand, was completely resistant to Tetracycline. Both strains of L. 
rhamnosus were susceptible to Penicillin (10 µg), Chloramphenicol (30 µg) and Clindamycin (2 
µg), but only one of them (strain HFI-K2) was susceptible to Ampicillin (10µg) and Meropenem 
(10 µg). L. reuteri HFI-LD5 displayed intermediate resistance to Kanamycin (30 µg), 
Nitrofurantoin (300 µg) and Chloramphenicol (30 µg).  L. reuteri DSM 17938, on the other hand, 
was completely resistant to all three of these antibiotics. Both strains of L. reuteri were susceptible 
to Rifampicin (5 µg) and Tobramycin (10 µg).  Strain HFI-LD5 differed from strain DSM 17938 
in being susceptible to Ampicillin (10 µg) and Clindamycin (2 µg). 
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L. reuteri DSM17938, L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 showed a significantly 
higher affinity for chloroform and a much lesser affinity for hexadecane (Table 2.1). The basic 
properties of L. reuteri HFI-LD5 and DSM 17938 were further supported by the significantly 
higher affinity for the non-polar solvent decane over basic ethyl acetate (Table 1). Of the four 
strains tested, L. rhamnosus HFI-K2 had the highest affinity for hexadecane (37.71 % ± 8.02 %), 
suggesting that the cell surface of the strain is hydrophobic.  Cells of L. rhamnosus R-11 had a 
much lower affinity (6.24 % ± 2.1 %) for hexadecane and was more-or-less similar to results 
obtained for L. reuteri HFI-LD5 and L. reuteri DSM 17938 (4.91 % ± 2.21 %).  
 
Table 2.1. Affinity of Lactobacilli isolates and reference strains for non-polar and monopolar 
solvents (MATS analysis). 
 
Standard deviation is given in parentheses. 
1 Significant differences in chloroform affinity between lactobacilli. 
2 Significant differences in ethyl acetate affinity between lactobacilli. 
3 Significant differences in affinity for hexadecane between L. reuteri HFI-LD5 and L. rhamnosus 
HFI-K2 (P = 0.002). 
4 Significant differences in affinity for hexadecane between L. rhamnosus HFI-K2 and L. 
rhamnosus R11 (P = 0.001).  
 
 
Of the four strains studied, L. rhamnosus HFI-K2 displayed the highest percentage auto-
aggregation (Figure 2.1 D), with cells aggregated to the extent that a distinct clearing of the upper 
part of the cell suspension was visible after 3 h of incubation. This correlated with the high affinity 
strain HFI-K2 had for hexadecane (Figure 2.2).  
Organism % Affinity 
 Chloroform Hexadecane Ethyl acetate Decane 
L. reuteri HFI-LD5 30.73 (6.17)1 8.82 (4.89)3 0.63 (0)2 24.37 (0) 
L. reuteri DSM 17938 15.82 (0.80)1 4.91 (2.21) 3.46 (1.95)2 14.96 (2.90) 
L. rhamnosus HFI-K2 94.18 (3.61)1 37.71 (8.02)3,4 60.59 (5.40) 75.15 (2.52) 
L. rhamnosus R11 11.29 (1.36) 6.24 (2.11)4 16.54 (2.34) 15.04 (2.58) 
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Figure 2.1. Comparison of the autoaggregating ability of L. reuteri HFI-LD5, L. rhamnosus 
HFI-K2 and reference strains, L. reuteri DSM 17938 and L.rhamnosus R-11. Each of the four 
graphs represent the following comparisons: (A) L. reuteri HFI-LD5 (●, Red line) and L. 
rhamnosus HFI-K2 (, Blue line). (B) L. reuteri HFI-LD5 (●, Red line) and the reference strain 
L. reuteri DSM 17938 (, dotted line). (C) L. rhamnosus HFI-K2 (, Blue line) and L. rhamnosus 
R-11 (, Dotted line). (D) Comparison of both isolates and reference strains, with the same keys 
as above. The error bars represent standard deviations of 3 independent experiments. 
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Figure 2.2. The relationship between autoaggregation and hydrophobicity of Lactobacillus 
strains. (●) L. reuteri HFI-LD5 (●) L. reuteri DSM 17938 (●) L. rhamnosus HFI-K2 (●) L. 
rhamnosus R-11. Cell surface hydrophobicity is expressed as the percentage bacteria adsorbed by 
hexadecane.  
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Cell-free supernatants of all four strains inhibited the growth of L. monocytogenes EDG-e, but not 
L. sakei LMG 13558.  However, neutralized cell-free supernatant (pH 6.5 to 7.5) had no effect on 
the growth of the two-target species. 
 
Lactobacillus reuteri HFI-LD5 formed a slight biofilm after 72 h of incubation at 37°C in the 
presence of MRS (Figure 2.3). Substitution of glucose with gluconate (mMRS medium) increased 
biofilm formation (Figure 2.3). MRS media allowed for only slight biofilm formation under the 
culturing conditions, however the substitution of glucose for gluconate resulted in a marked 
increase in biofilm formation. All lactobacilli strains exhibited biofilm formation when cultured in 
mTSB, irrespective of the concentration. When cultured in mTSB, L. rhamnosus HFI-K2 exhibited 
the best biofilm formation properties on a hydrophobic surface (polystyrene) of all the strains and 
various media compositions used. Interestingly, minimal biofilm formation was observed for either 
L. reuteri DSM 17938 or L. rhamnosus R-11, irrespective of the media or concentration (Figure 
2.3), clearly illustrating the extensive strain variability with respect to biofilm formation on 
polystyrene.  
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Figure 2.3. Comparison of biofilm formation capacity by Lactobacillus reuteri and 
Lactobacillus rhamnosus spp. Capacity of the two human fecal isolates (L. reuteri HFI-LD5 and 
L. rhamnosus HFI-K2) were compared to L. reuteri DSM 17938 and L. rhamnosus R-11 under 
different culture conditions (Nutrient rich, different carbon source and low C/N ratio). The results 
are expressed as the mean of two independent experiments, with nine biological repeats each. 
Standard deviation represented by error bars. 
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2.5. Discussion 
 
A juxtaposition exists between the requirement of the human body to protect against infection and 
the selective colonization by beneficial allochthonous and autochthonous microorganisms, which 
contribute to the maintenance of gastrointestinal tract (GIT) homeostasis. The ability of lactobacilli 
to survive the harsh conditions within the human GIT is well documented, with pH values in the 
stomach ranging from pH 1.5 to 3.0 and bile concentrations within the intestines reaching 0.5 % - 
2.0 % (28–30). Although Lactobacillus spp. are able to withstand these stresses, these species only 
represent 7 % of the total HGM (7). This underrepresentation was evident during the isolation of 
lactobacilli in this study, in which a limited number of acid producing, Gram positive, catalase 
negative and hemolytic negative bacilli were isolated (n = 4) from the human fecal matter.  
 
The genus Lactobacillus is the largest and most diverse genus amongst lactic acid bacteria (LAB). 
However, on a taxonomical front there is still a lack of clarity, with large numbers of lactobacilli 
having been classified based on phenotypic characteristics and a single gene, namely the 16S rRNA 
gene (31). This leads to limited species delineation, and there is thus a need for multiple other gene 
sequences or whole genome sequencing to be used for adequate Lactobacillus spp. identification. 
Therefore the 16S rRNA gene and recA gene were independently used for identification of the 
isolated strains (31, 32).  
 
Mucus, comprised of a thick loose, outer layer and a dense, stratified inner layer, is considered to 
be an evolutionary defense mechanism within the human GIT (33). Mucus consists of glycoprotein 
mucins, which can be degraded and utilized as a complex carbohydrate by certain lumen bacteria 
(34, 35). A select few commensals within the human GIT are capable of metabolizing and utilizing 
mucin although never to the same degree as pathogenic microorganisms (34, 36, 37). Both L. 
reuteri and L. rhamnosus spp. are known to form close associations with the mucosal surface 
within the GIT (38). Mucinolytic activity is not characteristic for either L. reuteri or L.  rhamnosus 
spp. which is in agreement with results obtained in this study (22, 39). This implies the lack in 
both L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 of the enzymes that are required to degrade 
and utilize mucin as a potential carbon source (35–37).  
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Both L. reuteri and L. rhamnosus spp. have been assigned GRAS status owing to their general 
inherent health benefits and low prevalence of infections. A few isolated cases of Lactobacilli-
associated infections have, however, been documented. These cases are rare and generally a result 
of a complication of other medical disorders and diseases (40). Lactobacilli susceptibility to 
antibiotics is species-specific and even strain-specific (41). L. reuteri and L. rhamnosus spp. have 
been documented as having intrinsic resistance to tetracycline, which matches the results seen in 
this study (42–44). The effective use of β-lactams against lactobacilli is variable. However, 
inhibitory activity is seen, as found in this study (45, 46). 
 
The interaction of microbes with abiotic and biotic surfaces has been studied for decades, however, 
the interaction of microbes with one another and with human cells has only come to the fore in 
recent years (47, 48). Microbial persistence within the human GIT relies on their ability to interact 
not only with one another but also with the host’s mucosal layers and epithelial cells. Numerous 
groups have listed factors such as cell surface proteins, cell surface hydrophobicity, 
autoaggregation ability and surface appendages (pili) as having an influence on the interaction and 
adhesion of microbes to various surfaces (26, 49, 50). 
 
The adhesion of microbial cells to abiotic and biotic surfaces is governed by complex interactions 
between van der Waals, Lewis acid-base and electrostatic forces (51, 52). Our results indicate that 
the cell surfaces of both L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 are basic or electron 
donating, with L. rhamnosus HFI-K2 being a stronger electron donor and weaker electron acceptor 
than the other Lactobacillus spp. in this study (Table 2.1). This is due to the physiochemical 
properties of the microbial cell surfaces varying at a species level (53). The high chloroform 
affinity observed for L. rhamnosus HFI-K2 (Table 2.1) is characteristic of the species (53). The 
basic properties of L. rhamnosus HFI-K2 may be due to the abundance of carboxylic and phosphate 
groups over amino groups. This increased basic and negative charge on the surface may benefit 
adhesion to biotic surfaces such as tissue (54). 
 
Cell surface hydrophobicity has been associated with the first steps involved in colonization and 
interaction with host mucosal layers, owing to its effect on the adhesion behavior of microbial cells 
(55, 56). Cell surface hydrophobicity of lactobacilli can be classified according to one of three 
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categories, namely low (0-35 %), moderate (36-70 %) and high (70-100 %) (57). The results of 
the hydrophobicity assay indicate that L. reuteri HFI-LD5 and both reference strains are weakly 
hydrophobic in nature (˂ 35 %), with L. rhamnosus HFI-K2 exhibiting a moderate degree of 
hydrophobicity (Table 2.1 and Figure 2.2). Similar results have been reported by other groups, 
with various lactobacilli (strain independent) possessing weakly hydrophobic cell surface 
properties and a few lactobacilli strains being hydrophobic in nature (53, 57, 58). 
 
The formation of microbial aggregates is important in several ecological niches, such as the human 
GIT, and has been identified as a desirable property for probiotics to possess for the initial 
colonization of the host (50, 59). All of the strains indicated a moderate degree of autoaggregate 
formation, with L. rhamnosus HFI-K2 presenting the highest autoaggregative capacity among the 
strains tested (Figure 2.1). The aggregation of the isolates may provide a protective shield against 
the harsh conditions within the human GIT and furthermore allow for transient GIT colonization 
(50, 60). A positive correlation was observed between autoaggregation ability and cell surface 
hydrophobicity of the lactobacilli strains. Although L. rhamnosus HFI-K2 demonstrates a 
moderate degree of autoaggregate formation and cell surface hydrophobicity, it did not cluster with 
L. reuteri HFI-LD5 or the reference strains (Figure 2.2). These findings are corroborated by 
numerous other studies both within and outside of LAB research, that show a positive correlation 
between microbial cell autoaggregation and microbial cell surface hydrophobicity (26, 50, 60, 61).  
 
The attachment and persistence of probiotics in the human GIT is a critical factor, since the ability 
to colonize is required to ensure that their beneficial effects are exerted. The study of probiotic 
persistence within the GIT generally involves in vitro cell line models or animal models. However, 
little attention is given to the potential for bacterial biofilm on the surface of the epithelial cells. 
Here we show that both L. reuteri HFI-LD5 and L.rhamnosus HFI-K2 are capable of forming in 
vitro biofilms on abiotic surfaces, in contrast to the respective control strains tested (Figure 2.3). 
This strain dependent variation with respect to in vitro biofilm formation is well established (19, 
62, 63). The lack of adequate biofilm formation at both concentrations of MRS (Figure 2.3 
) is corroborated by various other studies, wherein it was found that the high glucose concentration 
and presence of the surfactant, Tween 80, repressed biofilm formation (19, 63).  
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The ability of L. rhamnosus HFI-K2 to form biofilms on the hydrophobic polystyrene surface 
when cultured in mMRS and mTSB was clearly illustrated in this study, and is supported by the 
significantly higher cell surface hydrophobicity exhibited by this strain (Figure 2.3 and Table 2.1). 
It is well established that cell surface properties, especially hydrophobicity, are positively 
correlated to biofilm formation (64, 65). Biofilm formation by lactobacilli spp. is dependent on the 
strain and environmental conditions, as can be seen from this study and others (19, 62, 63). The 
intrinsic ability of the two novel isolates to form biofilms under in vitro conditions may contribute 
to the colonization ability of these two strains in vivo.  
 
It was established that L. rhamnosus HFI-K2 exhibits similar intrinsic tolerance to the stresses 
experienced within the human GIT, as L. reuteri HFI-LD5. The two strains share similar 
characteristics with their corresponding reference strains, L. reuteri DSM 17938 and L. rhamnosus 
R-11, both of which are commercially available probiotics. L. rhamnosus HFI-K2 exhibited a 
higher degree of hydrophobicity in conjunction with a better ability to form biofilms on 
hydrophobic abiotic surfaces. The ability to survive acid and bile stresses coupled with biofilm 
formation may contribute to persistence of these strains within the human gastrointestinal tract, 
especially L. rhamnosus HFI-K2. Further characterization is required to understand the 
mechanisms contributing to in vitro biofilm formation by L. rhamnosus HFI-K2, with expansion 
into formation of in vivo biofilms.  
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CHAPTER 3: Differential survival response of planktonic and sessile 
Lactobacillus rhamnosus HFI-K2 and Lactobacillus reuteri HFI-LD5 to fasting-
state human gastrointestinal conditions  
 
3.1. Abstract 
 
Most research on gut microbiota, including probiotic bacteria, focus on planktonic cells, even 
though evidence exists in support of microbial biofilm formation in sections of the GIT. The effect 
of three simulated, fasting-state gastrointestinal fluids (gastric fluid, pH 2, 2 h exposure; intestinal 
fluid, pH 7.5, 6 h exposure and colonic fluid pH 7, 24 h exposure) on planktonic and sessile cell 
viability of Lactobacillus reuteri (strain HFI-LD5) and Lactobacillus rhamnosus (strain HFI-K2), 
isolated from the human GIT, is described. The viability of batch-cultivated planktonic cells after 
exposure to gastric, small intestinal and colonic fluids could only be assessed individually, whereas 
biofilms were exposed sequentially to each of the gastrointestinal fluids while monitoring CO2 
production as an indicator of metabolic activity. Simulated gastric juice exposure had the greatest 
effect on planktonic cell viability and biofilm metabolic activity. A decline in planktonic cell 
numbers of L. reuteri HFI-LD5 from 3.8 x 106 CFU.ml-1 to 2.8 x 103 CFU.ml-1 was observed 
during the 2 h exposure period to gastric fluid, whereas cell numbers of L. rhamnosus HFI-K2 
showed a decline from 4.3 x 106 CFU.ml-1 to 0 CFU.ml-1. Exposure of L. reuteri HFI-LD5 and L. 
rhamnosus HFI-K2 biofilms to similar conditions initiated the detachment of biofilm biomass, 
accompanied by a decrease in metabolic activity, as recorded by changes in CO2 production. 
However, as soon as the exposure was halted and the simulated colonic fluid was replaced with 
sterile culture medium, the remaining biofilm biomass responded by producing CO2, followed by 
recovery and re-establishment of pre-exposure activity within 24 h. In contrast to the complete loss 
of planktonic L. rhamnosus HFI-K2 cell viability after exposure to gastric juice, biofilms of this 
strain not only recovered within 24 h after exposure, but exhibited increased metabolic activity 
after recovery. To the best of our knowledge, this is the first study to assess the effect of simulated, 
fasting-state gastrointestinal fluids on biofilms of L. reuteri and L. rhamnosus. The use of CO2 
production as a real-time indicator of biofilm metabolic activity provides insight into the 
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differential survival responses of lactic acid bacteria under human simulated fasting-state 
gastrointestinal conditions.  
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3.2. Introduction 
 
Renewed interest in functional foods and probiotics is predominantly driven by the increase in 
public awareness of critical functions fulfilled by the human GIT and the importance of 
maintaining GIT homeostasis (1–3). This led to the development of several new probiotic 
formulations with strains other than Lactobacillus and Bifidobacterium ssp. Probiotic bacteria need 
to survive conditions in the GIT to be of benefit to the host, thereby fulfilling the definition of a 
probiotic as being "live micro-organisms which, when administered in adequate amounts, confer 
a health beneﬁt on the host" (4–7). 
 
The human GIT is an intricate organ system that hosts various immunological and metabolic 
functions (8–10) and contains the greatest microbial diversity and density associated with the 
human body (11). The diverse GIT ecosystem supports a well-balanced symbiosis between 
eukaryotic and prokaryotic cells, regulated by changes in chemical and physical conditions (12). 
Microbial survival and growth in the GIT is mainly influenced by changes in pH, bile 
concentrations and transit times. This gives rise to the development of distinct environmental 
niches in the three major regions of the GIT, i.e. the stomach, small intestine and colon (13, 14). 
Microorganisms in the stomach are challenged by the high acidity of gastric fluid, digestive 
enzymes and often rapid luminal flow rates, depending on the nature of the stomach content (15). 
Stomach pH varies between 1.0 and pH 5.0, with the lowest values recorded during fasting (16–
21). Transit times from entering through the esophageal sphincter to leaving through the pyloric 
sphincter may be as rapid as 15 min or in excess of 130 min (16–18, 22). These harsh conditions 
are thought to largely prevent microbial colonization of the stomach, which puts a limit on the 
number of viable cells reaching the lower GIT. Microbes that do survive conditions in the stomach 
do not necessarily survive the high bile concentrations and sudden changes in pH in the first section 
of the small intestine, which varies between pH 4.0 and 8.0 (15, 16, 23). Transit time through the 
small intestine varies from 30 min to 6 h (16). However, the colonic region of the GIT is the most 
favorable to microbial colonization due to the relative pH stability, a near-neutral pH (pH 5.5 to 
7.5), lower bile concentrations and slow transit time (approximately 24 h), thus allowing for 
microbial establishment and proliferation (23–25).  
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The microbial diversity, activity and its association with the host are postulated to be enhanced by 
the presence of biofilms. Microbial biofilms associated with intestinal epithelial cells would 
facilitate metabolic interaction by shortening the distance across which metabolites must diffuse 
and prolonging the period of association, in contrast to free-floating planktonic cells in the GIT 
lumen. Biofilms are broadly defined as a community of microorganisms that assemble at an 
interface and encase themselves within a protective extracellular polymeric substance (EPS) 
matrix (29). Planktonic or suspended microbial growth is atypical in natural environments, with 
sessile biofilm formation thought to be the dominant mode of growth (27).  
 
Most studies on microbial biofilm formation in humans focus on the oral cavity (oral caries and 
periodontitis), specific diseases, such as cystic fibrosis, and soft tissue infections, including burn 
wounds, prosthetic devices and stents (28, 29). The study of biofilms within the context of the 
human GIT has been problematic, owing to the lack of non-destructive sample preparation 
techniques and the invasive nature of sample acquisition from human subjects (11, 30, 31). These 
difficulties may explain why more is known about the biofilm-epithelial cell associations observed 
in the upper GITs of animals, including pigs, rodents and chickens (11, 30, 32). During the course 
of the last two decades very few novel studies relating to microbial biofilms within the human GIT 
have been conducted, with instead a larger number of reviews on this topic being published (11, 
31, 33). The role of biofilms in microbial survival in the GIT of humans is thus largely unknown. 
Probiotic research has focused on the study of planktonic microorganisms, and this narrow focus 
has most likely caused an underestimation in the survival ability of probiotic microorganisms 
within the human GIT, owing to increased tolerance to stress conditions observed within microbial 
biofilms (34, 35). Therefore, the potential role of biofilm formation in the survival and persistence 
of probiotic and other microbes within the GIT remains unresolved to a significant extent. 
 
In this study, we report on the differential survival of batch-derived planktonic and biofilm cells 
of Lactobacillus reuteri HFI-LD5 and Lactobacillus rhamnosus HFI-K2, isolated from the human 
GIT, in the presence of gastrointestinal fluids that simulate a fasting condition. The ideal scenario 
for the evaluation of survivability would involve sequential exposure of the same microbes to the 
simulated gastric fluids (gastric, intestinal, and lastly colonic fluid), followed by recovery in 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 98 
growth medium. The free-floating nature of planktonic cells complicates this ideal testing scenario, 
since the recovery of cells with centrifugation, followed by washing steps, prior to exposure to the 
next simulated gastric fluid may introduce unknown variability and lead to the loss of biomass. 
Instead of sequential exposure, the survival of planktonic cells, cultivated in batch, was evaluated 
after separate exposure to each simulated fluid. Biofilm survival and recovery during sequential 
exposure to the simulated gastric fluids was monitored in real-time by recording the production of 
CO2 as an indicator of metabolic activity. 
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3.3. Materials and Methods 
 
3.3.1. Strains and growth conditions 
 
Lactobacillus reuteri HFI-LD5 and Lactobacillus rhamnosus HFI-K2, isolated from stool samples 
of healthy individuals, were cultured in MRS broth (36), but with glucose substituted by 20 g.l-1 
K-gluconate (mMRS). Incubation was at 37°C in anaerobic jars (Oxoid Ltd., Hampshire, UK), 
equipped with Anaero Pack-MicroAero gas-generating sachets (Mitsubishi Gas Chemical Co., Inc, 
Tokyo, Japan). Planktonic and biofilm survival experiments were performed at 37°C, in mMRS 
(pH 5.5).  
 
3.3.2. Preparation of simulated fasting-state gastrointestinal fluids 
 
Simulated intestinal fluid powder (Biorelevant Media, London, UK) was used to prepare fasting-
state simulated gastric fluid (SGF) and fasting-state simulated intestinal fluid (SIF), as prescribed 
by the manufacturer. The pH of SGF and SIF was adjusted to 2.0 and 7.5, respectively, with 1 M 
HCl and NaOH respectively. Simulated colonic fluid (SCoF) was prepared in phosphate-buffered 
saline (PBS, pH 7.0), according to Marques et al. (39). 
 
3.3.3. Survival of batch-cultured planktonic cells of L. rhamnosus HFI-K2 and L. 
reuteri HFI-LD5 in the presence of SGF, SIF and SCoF 
 
L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 were cultured separately in mMRS broth for 18 h 
at 37 ˚C, the cells harvested (2 000 x g, 10 min, 4°C) hereby minimizing damage to cells, washed 
twice with PBS (pH 7.0) and resuspended to an OD600nm of 0.8. One milliliter of each cell 
suspension was added to 9 ml SGF, SIF and SCoF, respectively, briefly vortexed and incubated at 
37°C in anaerobic jars (Oxoid Ltd., Hampshire, UK), equipped with Anaero Pack-MicroAero gas-
generating sachets (Mitsubishi Gas Chemical Co., Inc, Tokyo, Japan) on a shaker. Samples were 
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taken at specific time intervals (Table 3.1), serially diluted in Maximum Recovery Diluent (MRD, 
Oxoid) and plated onto MRS Agar (Biolab, Biolab Diagnostics, Midrand, SA). Plates were 
incubated at 37°C and colonies counted after 48 h. 
 
3.3.4. Survival of L. rhamnosus HFI-K2 and L. reuteri HFI-LD5 biofilms in the 
presence of SGF, SIF and SCoF 
 
The GIT environment was simulated using the CO2 evolution measurement system (CEMS) 
described by Kroukamp et al. (39). The system, schematically presented in Figure 3.1, consisted 
of 1.5 m long, thin-walled, silicon tubing (Freudenberg Medical, Carpinteria, CA, USA) with an 
inner diameter of 1.58 mm (outer diameter = 2.4 mm), encased in E-3603 Tygon tubing (VWR 
International, Mississauga, ON, Canada) with an inner diameter of 4.8 mm (outer diameter = 7.9 
mm). The volume of the inner thin-walled silicon tubing was 2.94 ml. Each end of the tubing was 
sealed with a 17 x 10 mm custom-made connector, fitted with separate gas and liquid ports. The 
gas port of the upstream connector connected the annular space between the outer silicone tubing 
surface and the inner Tygon tubing surface to a compressed gas cylinder containing high purity N2 
(Afrox, Cape Town, South Africa). The downstream gas port was connected to a non-dispersive, 
infrared LI-820 CO2 gas analyzer (LI-COR Biosciences, Lincoln, NE, USA). The flow rate of N2 
through the annular space was controlled at 20 ml.min-1 by using a GFM17 thermal gas mass flow 
controller (Aalborg Instruments and Controls, Inc., Orangeburg, NY, USA). 
 
Culture medium and fasting-state simulated gastrointestinal fluid reservoirs were connected 
upstream of the CEMS via the liquid port of the custom connector to the inner, thin-walled, silicone 
tubing. A custom-made, airtight, 6-port borosilicate glass manifold, equipped with a bubble trap, 
was inserted upstream of CEMS to allow sequential switching between medium and simulated 
gastric fluids without introducing air into the system. The manifold was connected to a 205U 
multichannel peristaltic pump (Watson-Marlow Fluid Technology Group, Falmouth, Cornwall, 
UK) with E-3603 Tygon tubing (Saint-Gobain Performance Plastics, Charny, France) of 1.6 mm 
inner diameter and 3.2 mm outer diameter. Changes in effluent pH were recorded downstream of 
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CEMS with a Vernier pH sensor using LabPro and Logger Pro 3.10.1 software (Trac, Stellenbosch, 
South Africa), housed in custom borosilicate glass T-pieces. Changes in CO2 production and 
effluent pH were logged continuously at 1 min intervals for the duration of the experiment. 
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Figure 3.1. Schematic diagram of the carbon dioxide evolution measurement system 
(CEMS). Medium and fasting-state simulated gastrointestinal fluids were smoothly and 
sequentially introduced into CEMS via the fluid manifold/bubble trap (A) from the respective 
reservoirs at a flow rate of 12.5 ml.h-1 provided by the peristaltic pump. CEMS was contained in a 
heating/cooling water bath set at 37°C (B). CEMS consists of thin-walled silicone tubing, encased 
within Tygon tubing with a larger inner diameter. CO2 produced by the biofilm growing on the 
inner surface of the silicone tubing diffuses across the CO2-permeable silicone into the annular 
space where it is contained by the Tygon tubing. The sweeper gas (high purity nitrogen) was 
introduced into the annular space of CEMS (expanded B, red shaded region) via a thermal gas 
mass flow controller at a rate of 20 ml.min-1, hereby collecting biofilm-derived CO2 prior to the 
gas mixture being analyzed by the CO2 analyzer. Effluent samples for the enumeration of biofilm-
derived planktonic cells were collected downstream of CEMS via a sampling port (C) prior to 
effluent entering the pH manifold (housing the pH electrode) thereby facilitating real-time pH 
measurements. Fluid lines and flow (─) and Gas lines and flow (─). All dimensions are to nearest 
mm. 
 
3.3.5. Survival of L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 in biofilms exposed 
to SGF, SIF and SCoF 
 
The CEMS was sterilized by flushing with 3.5 % (vol/vol) sodium hypochlorite for 2 h and then 
rinsed overnight with a constant flow of sterile distilled water. Culture medium (mMRS) was 
pumped through the inner silicone tubing for 1 h at a flow rate of 12.5 ml.h-1 to record baseline 
values for CO2 and pH. Thereafter, medium flow was stopped and the CEMS inoculated with 1 ml 
of an actively growing culture (OD600 = 0.8 in mMRS) of L. reuteri HFI-LD5, followed by 1.5 h 
of stagnant conditions to allow adhesion of the bacteria to the inner wall of the thin-walled silicon 
tube. The CEMS tubing was then submersed in a temperature-controlled water bath set at 37°C 
and the flow of mMRS resumed at 12.5 ml.h-1 (0.21 ml.min-1). At this flow rate, the retention time 
in the system was 14 min, thereby selecting for biofilm formation and restricting planktonic cell 
replication in the CEMS to a minimum. The flow of mMRS was maintained for up to 120 h to 
allow biofilm formation and stable CO2 production, indicative of a culture in steady-state 
metabolic activity. The medium was replaced by SGF, at a flow rate of 12.5 ml.h-1 for 2 h, followed 
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by SIF for 6 h and SCoF for 24 h at the same flow rate. The experiment was performed in duplicate 
for L. reuteri HFI-LD5 and L. rhamnosus HFI-K2. 
Effluent from the CEMS was collected at specific time points (Table 3.1) at the sampling port 
upstream of the pH sensor. Serial dilutions were made in sterile saline and plated onto MRS Agar 
(Biolab). Viable cell numbers were determined after 48 h of incubation at 37˚C. These cell 
numbers represented biofilm-derived planktonic cells produced during biofilm establishment and 
recovery, as well as detaching biofilm biomass during exposure to simulated gastrointestinal 
fluids. 
In a separate experiment, the effect of 2 h SGF exposure, followed by recovery growth medium 
on L. reuteri HFI-LD5 biofilms was evaluated with respect to CO2 production, effluent pH and 
biofilm-derived cell numbers, as described above. To account for the effect pH on the solubility 
of CO2, sterile mMRS, SGF, SIF and SCoF were injected into the CEMS and readings recorded 
as described. 
 
3.3.6. Statistical analysis 
 
Significant differences in bacterial cell numbers were determined by conducting unpaired t-tests 
in IBM SPSS Statistics 22 (IBM Corp. Armonk, NY). A p-value of ˂ 0.05 was considered 
statistically significant. Batch-derived planktonic cell experiments were conducted in triplicate, 
whilst biofilm studies were performed in duplicate. 
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3.4. Results 
 
Batch-derived planktonic cell numbers of L. rhamnosus HFI-K2 declined significantly from 4.3 x 
106 CFU.ml-1 to no detectable cell numbers within 40 min of exposure to SGF (pH 2.0) (Figure 
3.2A). In contrast, the number of viable planktonic cells of L. reuteri HFI-LD5 declined from 3.8 
x 106 CFU.ml-1 to 2.9 x 104 CFU.ml-1 within the first 40 min of exposure to the same conditions, 
followed by a gradual decline to 2.8 x 103 CFU.ml-1 over the next 60 min (Figure 3.2A). 
The viability of batch-derived planktonic L. rhamnosus HFI-K2 cells remained unchanged at 5.0 
x 105 CFU.ml-1 during 6 h exposure to SIF (pH 7.5), whereas L. reuteri HFI-LD5 cell numbers 
declined rapidly from 4.1 x 106 CFU.ml-1 to 3.4 x 105 CFU.ml-1 during the first 2 h of exposure 
(Figure 3.2B). This was followed by a 2-h stabilization period and further significant reduction to 
3.7 x 104 CFU.ml-1 during the last 2 h (Figure 3.2B). Both strains showed similar survival trends 
during exposure to SCoF (pH 7.0), with the only significant difference in survival observed at 6 h 
(p ˂ 0.05). After 24 h exposure both L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 exhibited only 
a marginal reduction in overall viability (Figure 3.2C).  
 
During the first 80 h after inoculation of CEMS with L. rhamnosus HFI-K2, a steady decrease in 
effluent pH due to the metabolism of gluconate to lactic acid was observed (pH 5.5 to 4.9). This 
observation, accompanied by a slight increase in overall biofilm metabolic activity (CO2 
production) and a two-fold increase in the number of biofilm-derived planktonic cells released into 
the effluent, indicated that biofilm development had commenced (Figure 3.3 and 3.4). The rate of 
CO2 production by the biofilm rapidly increased once the pH dropped below 5.0. An initial steady-
state biofilm was reached at approximately 110 h with an effluent pH of 4.9 and the production 
and release of 1.5 x 1010 CFU.ml-1 of planktonic cells into the effluent (Figure 3.4). 
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Figure 3.2. Survival of planktonic Lactobacillus reuteri HFI-LD5 (●, red line) and 
Lactobacillus rhamnosus HFI-K2 (, blue line) in fasting-state simulated gastrointestinal 
fluids. (A) Fasting state simulated gastric fluid, pH 2.0 for 120 min; (B) Fasting state simulated 
intestinal fluid, pH 7.5 for 6 h; (C) Simulated colonic fluid, pH 7.0 for 24 h. The data represent the 
means of triplicate experiments and the error bars indicate standard deviation. Significant 
differences between the two strains (p ˂ 0.05) are indicated by *.  
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The subsequent introduction of SGF (pH 2.0) into the system at 123 h resulted in a notable and 
rapid decrease in biofilm metabolic activity (Figure 3.3). The metabolic stress induced by the 
acidic gastric fluid (pH 2.0) and the cessation of nutrient supply to the biofilm is clearly illustrated 
by the reduction in biofilm metabolic activity to approximately the same basal levels displayed by 
uninoculated growth medium (Figure 3.3). This curtailing of metabolic activity was accompanied 
by a sustained decline in pH and the loss of large amounts of biomass from the system, as was 
evident from the increasing effluent cell counts. Despite the loss of biofilm biomass, the effluent 
pH value never reached that of the SGF (pH 2.0), indicating that sufficient biomass remained 
within the system to confer buffering capacity (Figure 3.3).  
 
The subsequent switch to SIF (pH 7.5) at 125 h (Figure 3.3) had no detectable effect on biofilm 
activity, while the number of viable cells in the effluent decreased, further corroborating the lack 
of biofilm metabolic activity observed. The introduction of SCoF (pH 7.0) at 131 h exhibited no 
effect on the metabolic activity of the biofilm, potentially reflecting a state of metabolic dormancy 
(Figure 3.4 and 3.5). The decrease in biofilm biomass as a result of the previous two treatments 
resulted in a rapid decrease in from pH 7.5 to 7.0, which was maintained until the introduction of 
recovery growth medium at 155 h. Initiation of the recovery phase elicited a prompt metabolic 
response from the surviving biofilm biomass within the system (Figure 3.3). The reintroduction of 
growth medium facilitated the regrowth of the lost biofilm biomass to the extent that the steady-
state activity of the recovered biofilm exceeded the initial steady-state by 1.5-fold (Figure 3.3). 
The establishment of a higher steady-state was further corroborated by the effluent pH reaching 
pretreatment levels (pH 4.9) within 24 h of the reintroduction of growth medium (pH 5.5) and the 
sustained release of biofilm-derived planktonic cells to the effluent from 3 h post-treatment 
onwards (Figure 3.4 and 3.5). 
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Figure 3.3. Representative CO2 production rates, changes in effluent pH and biofilm-derived 
cell numbers of Lactobacillus rhamnosus HFI-K2 biofilms in response to sequential exposure 
to simulated gastrointestinal fluids. The introduction of fasting-state simulated gastric fluid at 
123 h (pH 2.0, 2 h in duration, purple shade), followed by fasting-state simulated intestinal fluid 
at 125 h (pH 7.5, 6 h in duration, pink shade); simulated colonic fluid at 131 h (pH 7.0, 24 h 
exposure interval, green shade); and the reintroduction of growth medium (pH 5.5, white shade). 
The solid black line indicates effluent pH, the blues lines represent L. rhamnosus HFI-K2 biofilm 
metabolic activity and the purple line indicates baseline CO2 values for the uninoculated growth 
medium and various SGF. The resilience of L. rhamnosus HFI-K2 biofilms to perturbations in pH, 
osmolarity and enzyme concentrations after exposure to simulated gastrointestinal fluids is 
evident, with anew steady-state achieved after reintroduction of medium into the system. The 
nested graph illustrates that abiotic influences (evolution of CO2 due to pH perturbations) are 
negligible. 
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Figure 3.4. Representative CO2 production rates and changes biofilm-derived cell numbers 
of Lactobacillus rhamnosus HFI-K2 biofilms in response to sequential exposure to simulated 
gastrointestinal fluids. The introduction of fasting-state simulated gastric fluid at 123 h (pH 2.0, 
2 h in duration, purple shade), followed by fasting-state simulated intestinal fluid at 125 h (pH 7.5, 
6 h in duration, pink shade); simulated colonic fluid at 131 h (pH 7.0, 24 h exposure interval, green 
shade); and the reintroduction of growth medium (pH 5.5, white shade). The dotted, black line 
indicates biofilm-derived cell, the blues lines represent L. rhamnosus HFI-K2 biofilm metabolic 
activity and the purple line in nested graph indicates pH changes. Biofilm-derived planktonic cell 
numbers enumerated from the CEMS effluent. The nested graph illustrates effluent cell number 
compared to perturbations in pH.   
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Figure 3.5. Focused representative CO2 production rates and changes biofilm-derived cell 
numbers of Lactobacillus rhamnosus HFI-K2 biofilms in response to sequential exposure to 
simulated gastrointestinal fluids during treatment phase. The introduction of fasting-state 
simulated gastric fluid at 123 h (pH 2.0, 2 h in duration, purple shade), followed by fasting-state 
simulated intestinal fluid at 125 h (pH 7.5, 6 h in duration, pink shade); simulated colonic fluid at 
131 h (pH 7.0, 24 h exposure interval, green shade); and the reintroduction of growth medium (pH 
5.5, white shade). The blues lines represent L. rhamnosus HFI-K2 biofilm metabolic activity and 
the dotted, black line represents cell numbers. A clear illustration of changes in cell numbers and 
metabolic activity during the treatment and recovery phase of L. rhamnosus HFI-K2. 
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No detectable CO2 was produced by L. reuteri HFI-LD5 during the initial 40 h post-inoculation 
period (Figure 3.6). A slight decrease in effluent pH as well as a two order of magnitude increase 
in biofilm-derived planktonic cell numbers released into the effluent (from 107 CFU.ml-1 to 109 
CFU.ml-1) (Figure 3.7 and 3.8) indicated that surface colonization had started. Thereafter, an 
exponential increase in biofilm CO2 production rate was observed, which was associated with a 
further decrease in effluent pH. The biofilm reached an initial metabolic steady-state with 5.5 μmol 
CO2 produced per hour after 60 h of incubation with an effluent pH of 5.0 (0.5 units lower than 
influent medium pH of 5.5). 
 
Similar to the response of L. rhamnosus HFI-K2 biofilms, the introduction of SGF at 69 h resulted 
in an initial spike in metabolic activity, prior to a rapid and notable decrease owing to the metabolic 
stress induced by the SGF (Figure 3.6). A significant increase in the cell numbers released into the 
effluent was observed at 40 min after commencement of treatment (up to 1010 CFU.ml-1), likely 
due to the detachment of biofilm biomass from within the system owing to the significant change 
of influent medium pH and the subsequent acid stress induced on the biofilm (Figure 3.7 and 3.8). 
 
The ensuing introduction of SIF at 71 h, followed by SCoF at 77 h resulted in CO2 detection rates 
similar to that observed for uninoculated growth medium. The effluent pH decreased and reached 
a minimum value of 2.7 after the 2 h of SGF exposure. The 0.7 pH unit difference observed 
compared to the influent SGF (pH 2.0) is attributable to the buffering capacity of the biomass 
within the system (Figure 3.6). During the subsequent exposure to SIF (pH 7.5) the effluent pH 
values detected downstream of the biofilm increased from pH 2.7 to 7.1. The decrease in pH during 
SIF treatment may again be credited to the remaining biomass within the system buffering the 
effect of the treatment (Figure 3.6). Despite not being able to detect biofilm activity throughout 
the treatment period (from 69 h to 101 h), viable biomass continued to detach from the biofilm 
(Figure 3.7 and 3.8). These viable cells are most likely the result of biomass detachment and not 
active biofilm-derived release of planktonic cells due to the absence of nutrients. Reintroduction 
of growth medium (pH 5.5) into the system subsequent to SGIF exposure at 101 h resulted in a 
prompt increase of biofilm metabolic activity and correlated with the release of more biofilm-
derived planktonic cells into the effluent (Figure 3.7 and 3.8), with the re-establishment of the pre-
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treatment steady-state metabolic activity within 10 h (Figure 3.7). This steady-state was disrupted 
by a sloughing event, followed by recovery and establishment of a new steady-state, with the new 
state being 1.2-fold higher than initial state (data not shown). The rapid response and recovery 
after the metabolic stresses induced by SGIF was accompanied by a decrease in pH from 5.5 to 
5.0 within 5 h of resumption of growth medium, which occurred nearly 10-fold faster than during 
the establishment of the biofilm (pre-40 h). An increase in biofilm-derived planktonic cell 
production to a log unit higher than the initial steady-state value corroborated the rapid recovery 
of biofilm biomass after exposure to SGIF and the establishment of a higher steady-state metabolic 
activity. 
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Figure 3.6. Representative CO2 production rates by Lactobacillus reuteri HFI-LD5 biofilms 
and accompanying changes in effluent pH and culturable biofilm-derived cell numbers 
during biofilm establishment and subsequent exposure to simulated fasting-state 
gastrointestinal fluids (SGIF). The introduction of simulated gastric fluid at 69 h (pH 2.0, 2 h in 
duration, purple); followed by simulated intestinal fluid at 71 h (pH 7.5, 6 h in duration, pink); 
simulated colonic fluid at 77 h (pH 7.0, 24 h exposure interval, green); and growth medium (pH 
5.5, white). The solid black lines indicate effluent pH, the red line represents the CO2 production 
rate of the L. reuteri HFI-LD5 biofilm and the purple line indicates baseline CO2 values for the 
uninoculated growth medium and various SGF. The results of one of the duplicate biofilm 
experiments are shown and are representative of the duplicate biofilm experiment. The response 
of the L. reuteri HFI-LD5 biofilm to the sequential introduction of SGIF is clearly visible in the 
main graph, with a new steady-state reached after recovery. The nested graph illustrates that pH 
perturbations had a negligible influence on CO2 evolution in comparison to the biotic response. 
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Figure 3.7. Representative CO2 production rates by Lactobacillus reuteri HFI-LD5 biofilms 
and accompanying changes in effluent pH and culturable biofilm-derived cell numbers 
during biofilm establishment and subsequent exposure to simulated fasting-state 
gastrointestinal fluids (SGIF). The introduction of simulated gastric fluid at 69 h (pH 2.0, 2 h in 
duration, purple); followed by simulated intestinal fluid at 71 h (pH 7.5, 6 h in duration, pink); 
simulated colonic fluid at 77 h (pH 7.0, 24 h exposure interval, green); and growth medium (pH 
5.5, white). The solid black lines indicate effluent pH, the red line represents the CO2 production 
rate of the L. reuteri HFI-LD5 biofilm and the purple line indicates baseline CO2 values for the 
uninoculated growth medium and various SGF. The results of one of the duplicate biofilm 
experiments are shown and are representative of the duplicate biofilm experiment. The correlation 
between biofilm development and an increase in biofilm-derived cells released from the system. 
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Figure 3.8. Focused representative CO2 production rates by Lactobacillus reuteri HFI-LD5 
biofilms and accompanying changes in effluent pH and culturable biofilm-derived cell 
numbers during biofilm establishment and subsequent exposure to simulated fasting-state 
gastrointestinal fluids (SGIF). The introduction of simulated gastric fluid at 69 h (pH 2.0, 2 h in 
duration, purple); followed by simulated intestinal fluid at 71 h (pH 7.5, 6 h in duration, pink); 
simulated colonic fluid at 77 h (pH 7.0, 24 h exposure interval, green); and growth medium (pH 
5.5, white). The solid black lines indicate effluent pH, the red line represents the CO2 production 
rate of the L. reuteri HFI-LD5 biofilm and the purple line indicates baseline CO2 values for the 
uninoculated growth medium and various SGF. The results of one of the duplicate biofilm 
experiments are shown and are representative of the duplicate biofilm experiment. An expansion 
of the treatment and recovery phases provides a clear illustration of changes in effluent cell 
numbers and L. reuteri HFI-LD5 biofilm metabolic activity. 
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Similar to previous results, the effect of the highly acidic SGF on a L. reuteri HFI-LD5 biofilm 
was evident (Figure 3.9). A rapid decrease in metabolic activity from 7 µmol CO2 .h
-1 to 3.5 x 10-
4 µmol CO2.h
-1 was detected within 5 min after the introduction of SGF to a 50-h old steady-state 
biofilm. A rapid and sustained increase in metabolic activity was observed upon the reintroduction 
of growth medium (pH 5.5) after the 2 h treatment period, with the establishment of a new steady-
state within 6 h of cessation of SGF treatment (Figure 3.9). Biofilm-derived effluent cell numbers 
decreased from 1.4 x 1011 CFU.ml-1 pretreatment to 4.1 x 109 CFU.ml-1 post-treatment, followed 
by the recovery to pre-treatment values (1011 CFU.ml-1) within 15 h (Figure 3.10 and 3.11).  
 
 
Figure 3.9. Representative CO2 production rates by a L. reuteri HFI-LD5 biofilm and 
accompanying changes in effluent pH and culturable biofilm-derived cell numbers during 
biofilm establishment and subsequent exposure to simulated fasting-state gastric fluid (SGF) 
for 2 h. Fasting-state simulated gastric fluid was introduced at 50 h (pH 2.0, 2 h in duration, purple) 
followed the reintroduction of growth medium (pH 5.5, white). Solid black lines indicate effluent 
pH, the red line represents the CO2 production rate. The response of the L. reuteri HFI-LD5 biofilm 
to acidic SGF introduced at 50 h, followed by a recovery of the pre-exposure steady-state within 
6 h after exposure to simulated gastric fluid. 
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Figure 3.10. Representative CO2 production rates by a L. reuteri HFI-LD5 biofilm and 
accompanying changes in effluent pH and culturable biofilm-derived cell numbers during 
biofilm establishment and subsequent exposure to simulated fasting-state gastric fluid (SGF) 
for 2 h. Fasting-state simulated gastric fluid was introduced at 50 h (pH 2.0, 2 h in duration, purple) 
followed the reintroduction of growth medium (pH 5.5, white). The red line represents the CO2 
production rate and the dotted, black line represents the biofilm derived cell numbers. Solid 
magenta line in nested graph indicate effluent pH. The correlation between biofilm development 
and an increase in biofilm-derived cells released from CEMS. During the treatment period, effluent 
cell numbers initially increased, most likely due to biomass detachment. After 60 min of exposure 
the cell numbers decreased prior to the reintroduction of growth medium (pH 5.5) whereupon a 
rapid increase in cell numbers was observed, which is further corroborated by the observed 
recovery of biofilm metabolic activity. The nested graph illustrates cell number compared to 
perturbations in pH.  
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Figure 3.11. Focused representative CO2 production rates by a L. reuteri HFI-LD5 biofilm 
and accompanying changes in culturable biofilm-derived cell numbers during biofilm 
establishment and subsequent exposure to simulated fasting-state gastric fluid (SGF) for 2 
h. An expanded view of the treatment and recovery phases as seen in Figures 3.9 and 3.10. Fasting-
state simulated gastric fluid was introduced at 50 h (pH 2.0, 2 h in duration, purple) followed the 
reintroduction of growth medium (pH 5.5, white). The red line represents the CO2 production rate 
and the dotted, black line represents the biofilm derived cell numbers.  
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3.5. Discussion 
 
The capability of facultative heterofermentative lactic acid bacteria (LAB) to metabolize hexoses 
to lactic acid, CO2 and ethanol/acetic acid in equimolar amounts is well-documented, whereas 
obligatory heterofermentative LAB metabolize both glucose and gluconate to the same metabolic 
end-products. This principle was exploited by monitoring CO2 production as an indicator of 
biofilm metabolic activity (40). In addition to quantifying the CO2 production rate, the in-line 
monitoring of effluent pH changes were indicative of organic acid production by the biofilm, 
thereby leaving only ethanol production unassessed (Figure 3.3, 3.6 and 3.9) (40).  
 
A number of Lactobacillus spp. is considered intrinsically resistant to the harsh environmental 
conditions, notably the perturbations in pH, enzyme concentrations and osmolarity, that occur 
within the human GIT (41–43). These bacteria employ various adaptations to circumvent and 
mitigate the metabolic and physiological stresses induced by acidic conditions. The ability of 
lactobacilli to tolerate acidified environmental conditions is due to the maintenance of a constant 
pH gradient between the intra- and extra-cellular environment (41). This constant pH gradient is 
established and maintained through various processes such as expulsion of protons through the 
F1F0-ATPase, glutamate decarboxylase systems, alkalization of the external environment, 
generalized stress response proteins, alterations to cell surface composition and repair of proteins 
(5, 44, 45).  
 
Although intrinsic resistance to GIT conditions may be present, the degree of such resistance varies 
among Lactobacillus spp., as is evident from this study. During exposure to SGF (pH 2.0, 2 h), 
planktonic cells of L. reuteri HFI-LD5 cultivated in batch exhibited significantly better tolerance 
to the prevailing acidic conditions and enzymatic stresses over the entire duration of exposure 
compared to the complete loss of viability exhibited by L. rhamnosus HFI-K2 within 40 min of 
treatment (Figure 3.2). The ability of L. reuteri strains to survive acidic conditions, and specifically 
gastric fluid, has been well documented (43, 45, 46). The survival and rapid recovery of L. reuteri 
HFI-LD5 biofilms following SGF exposure further illustrated its resilience to gastric fluid (Figure 
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3.6) and the potential for biofilm-association to enhance this persistence. L. reuteri strains are not 
only autochthonous to, but also the numerically dominant Lactobacillus species in the GIT of 
humans (47, 48). The autochthonous nature of L. reuteri strains, may therefore explain the 
significantly better survival of L. reuteri HFI-LD5 compared to L. rhamnosus HFI-K2.  
 
The complete loss of planktonic L. rhamnosus HFI-K2 culturability in SGF is most likely due to 
the prevailing acidic conditions (Figure 3.2). L. rhamnosus strains exhibit a greater sensitivity to 
acid stress than to bile stress, with drastic reduction or complete loss of viability when exposed to 
pH values lower than 3.0 (49). L. rhamnosus strains are indigenous to the oral cavity (48) and 
considered to be allochthonous to the human GIT. The reduced tolerance of this Lactobacillus 
species to acidic conditions may thus be indicative of a lack of the appropriate environmental 
adaptations required for stomach colonization (50, 51). The human stomach is considered to be 
largely devoid of microorganisms during the fasting period between meals, with those 
microorganisms that are present being Gram-positive, aciduric bacteria (31, 52). It is therefore not 
surprising that bacterial biofilms within the healthy human stomach have yet to be described, 
although microcolonies (biofilms) have been noted in individuals suffering from Barrett's 
esophagus (52). Several studies relating to biofilms within the upper GITs of mammals and birds 
have been published (51, 53), which may allude to the presence of biofilms in the human stomach. 
This hypothesis is supported by the findings in this study where L. rhamnosus HFI-K2 was able 
to survive the full duration of SGF exposure when cultivated as a biofilm, in contrast to its inability 
to survive short periods of exposure when grown planktonically (Figure 3.2 and 3.3).  
 
The near neutral pH and longer transit time within the small intestine renders this compartment 
more conducive to microbial colonization and proliferation. However, elevated bile levels in the 
small intestine may have detrimental effects on the bacteria entering this compartment, owing to 
its bacteriostatic action (15, 54). As previously mentioned, L. reuteri strains are considered to be 
autochthonous to the human GIT, specifically the intestinal tract (47, 51, 55), rendering it able to 
survive, proliferate and thus form stable populations under these environmental conditions. This 
accounts for the moderate reduction in planktonic L. reuteri HFI-LD5 viability during exposure to 
SIF (pH 7.5, 6 h) (Figure 3.2). The presence of bile and moderate duration of exposure to SIF had 
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a minimal effect on the viability of free-floating L. rhamnosus HFI-K2 (Figure 3.2). This 
maintenance of viability is corroborated by other studies, wherein L. rhamnosus strains exhibited 
elevated tolerances to bile induced stress, even in the presence of 2 % bile (56, 57). Although L. 
rhamnosus is considered to be allochthonous in the human GIT, the pH of SIF is close to that of 
the oral cavity (pH 6.8) where L. rhamnosus is a resident species, thereby potentially explaining 
the stability with respect to viability observed (50, 58). 
 
The human colon is considered to be the largest single reservoir of bacteria, both within the GIT 
and within the rest of the human body. This can be attributed to the properties inherent to the 
colonic environment, such as a near neutral pH (5.5 to 7.5), reduced bile concentrations, increased 
retention time, deep colonic crypts and abundance of energy sources in the form of non-digestible 
carbohydrates (37, 38, 59, 60). Autochthonous and allochthonous Lactobacillus species that 
survive the harsh conditions which prevail within the upper GIT are rapidly introduced into the 
ascending colon where these bacteria may colonize and subsequently proliferate (15, 47, 61). This 
is corroborated by the current observation regarding the survivability of planktonic L. reuteri HFI-
LD5 and L. rhamnosus HFI-K2 in SCoF (pH 7.5, 24 h) where a slight decrease in viability was 
observed (Figure 3.2). The lack of active proliferation within the SCoF can be attributed to the 
deficiency of nutrients owing to fasting-state experimental conditions being utilized.  
 
Although biofilms in the human intestinal tract have been described, a significant number of 
questions remain, owing to the difficulty of sample acquisition and inadequacy of preparation 
methods (11, 30, 31, 52). It has long been thought that the rapid transit time of digesta through the 
upper GIT limits permanent colonization, and although this may be partially true for the stomach, 
this assumption may be disputed in the case of the small intestinal tract. Two distinctive microbial 
communities exist within the small intestine and the colon, namely those associated with either the 
mucosa or the lumen (11, 52). The former community is the most challenging to investigate and 
therefore least studied, as this is the interface between the mucosal surface and luminal contents 
where biofilm formation can occur. Various studies, although not all involving the human GIT, 
have described the formation of microcolonies and complex heterogeneous biofilm communities 
on and in the mucosa of the intestinal tract (30, 46, 52, 62). Swidsinski et al. (63) studied mucosal 
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biopsies obtained from individuals with and without inflammatory gut disorders, and observed that 
individuals with inflammatory bowel disease had a mucosal biofilm mainly comprised of the 
Bacteroides/Prevotella group, whilst Gram-positive anaerobes dominated the mucosal biofilms in 
the non-inflamed group of individuals. Both L. reuteri and L. rhamnosus species have been 
observed to form microcolonies (biofilms) on the mucosa and in the mucus layers of the GIT, with 
biofilm formation and production of exopolysaccharides by L. rhamnosus GG being considered 
important attributes aiding GIT persistence (11, 32, 46, 64). These findings corroborate those 
presented here, wherein both Lactobacilli sp. were able to form in vitro biofilms that not only 
persisted, but also recovered rapidly after exposure to SGF.  
 
Microbes contained within a biofilm express a phenotype notably different from their planktonic 
counterparts and are protected from harsh environmental conditions due to the EPS matrix that 
encases the cells and facilitates the establishment of microenvironments (29, 31). The preference 
for sessile growth by microbes may be due to the inherent structural nature of biofilms provided 
by a protective matrix consisting of EPS, cellular proteins and other cells, which renders a suitable 
environment for microbial proliferation and persistence (27). Cells growing in a multicellular 
environment would garner protection afforded by a sessile biofilm lifestyle, in addition to being 
exposed to symbiotic or competitive intra- or inter-species interactions (27, 65, 66). Antibiotic 
tolerance within biofilms is the most well studied example of the remarkable differences that exist 
between biofilm-associated cells and planktonic cells (29). In vitro biofilm susceptibility studies 
have shown that biofilms tolerate antibiotic concentrations 100 to 1000 times higher than 
planktonic cells (29). These biofilm-related adaptations allow microbes to persist and survive 
under harsh environmental conditions, including pH changes and nutrient deprivation, which are 
experienced within compartments of the human GIT (29, 31, 62). Biofilm formation is thus 
especially important for survival in harsh environments such as the GIT where cells are exposed 
to a variety of chemicals, and fluctuation in pH and shear forces (67). This preference for sessile 
growth is, however, at variance with planktonic growth, since the latter is considered important 
for colonizing new niches, despite potentially being at the cost of survival and persistence (27).  
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Although the CEMS has allowed for the non-destructive, real-time monitoring and quantification 
of LAB biofilm metabolic activity, it is limited in some respects. The requirement of employing 
thin-walled silicone tubing (hydrophobic) as adhesion surface for both biofilm formation and gas 
exchange, may influence or preclude adhesion of hydrophobic LAB (Figure 3.1). The small 
diameter of the tubing combined with the invasive nature of pH measurement probes furthermore 
renders in situ pH monitoring impractical, thus preventing monitoring of pH changes within the 
biofilm structure, and limiting measurement to the effluent. While CEMS as an analytical 
technique provides valuable insight into whole-biofilm metabolism, it does not lend itself to the 
direct on-line quantification of biofilm biomass but rather indirect monitoring of, for example, the 
number of cultivable cells released or detached from the biofilm.  
 
To the best of our knowledge this is the first study to assess the effects of fasting-state 
gastrointestinal fluid on microbial biofilms rather than only planktonic cells. In accordance with 
existing literature, the robustness of bacterial biofilms compared to planktonically cultured 
bacteria was clearly observed in this study. Despite being subjected to nutrient deprived conditions 
simulating the fasting state between meals, significant pH fluctuations and enzymatic stresses, the 
respective lactobacilli biofilms were able to persist and recover, providing a unique insight into 
the differential survival response of these two LAB species compared to planktonic cells. These 
findings may lend credence to claims made by commercial probiotic manufacturers that their 
formulations persist within the human GIT, due to these formulations potentially giving rise to 
biofilms or integrating into existing biofilms within the GIT. 
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Concluding Remarks 
 
The rapid expansion of the probiotic field in the last two decades has provided some insight into 
the principles underpinning human gastrointestinal health. Although this understanding with 
respect to the immunological and physiological effects of probiotic supplementation on human 
health has ameliorated gastrointestinal dysfunction in many individuals, many unanswered 
questions remain. 
 
As a proxy for survivability under human GIT conditions, classical probiotic screening methods 
test the ability to tolerate stresses induced by both the acidic nature and the presence of bile under 
planktonic growth conditions. This study has clearly shown that although classical planktonic 
screening parameters may identify preferential probiotic candidates for further study, the survival 
and persistence potential of these candidates under GIT conditions require more in-depth 
evaluation.  
 
Despite the fact that the novel isolates identified in this study fulfilled the classical probiotic 
selection criteria, i.e. acid and bile tolerance, further examination of both L. reuteri HFI-LD5 and 
L. rhamnosus HFI-K2 highlighted the need to study probiotics in a manner that best incorporates 
all of the physiological factors within the GIT, including physiologically relevant fluid 
composition and concentrations, as well as mode of growth. This was evident when planktonic 
suspensions of both isolates were exposed to simulated fasting-state gastrointestinal fluids; even 
though both strains were selected for tolerance to low pH environments, a differential survival 
response was observed. Based on this observation, it was expected that the exposure of biofilms 
of both strains to the simulated gastric fluids would result in the same response. However, in 
contrast to the planktonic response, biofilms of both strains survived and persisted despite 
exposure to the same harsh environmental conditions. This emphasizes the importance firstly of 
examining microorganisms under biologically relevant conditions, and secondly that the 
differential responses to stress conditions observed between planktonic and sessile bacterial 
populations extends to probiotic microorganisms.  
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The ability of probiotic microbes to tolerate and proliferate in the presence of bile is critical for 
survival and persistence within the human GIT, owing to its bacteriostatic properties. In this study 
the inhibitory effects of bile are illustrated, since the addition of bile salts to standard culture media 
(MRS) differentially affected the rate and extent of planktonic growth of both L. reuteri HFI-LD5 
and L. rhamnosus HFI-K2, although only minor detrimental effects were observed. L. rhamnosus 
HFI-K2 was more susceptible to bile compared to L. reuteri HFI-LD5, which is characteristic of 
the L. rhamnosus spp. This observed susceptibility of L. rhamnosus HFI-K2 was however 
contradicted when the two strains were exposed to simulated fasting-state gastrointestinal fluids, 
specifically the simulated fasting-state intestinal fluid. The physiologically relevant concentration 
of bile present in the simulated fluid had a distinct effect on planktonic L. reuteri HFI-LD5 
viability, with no observable effect on L. rhamnosus HFI-K2. However, when the two strains were 
allowed to form biofilms prior to simulated fasting-state gastrointestinal fluid exposure, the 
bacteriostatic effect of bile on these microorganisms appeared to be mitigated entirely. These 
contradictions may be due to the influence of media components, pH or to the actions of digestive 
enzymes. Regardless of the cause, this observation underlines the importance of examining 
probiotic response to stress conditions under different growth conditions and with specific 
experimental objectives in mind. 
 
Probiotic research has always kept pace with the ever-evolving scientific research field, with the 
progression from classical microbiology to “omics” orientated microbiology in recent years. This 
constant evolution has allowed for the expansion of our knowledge in the fields of 
gastroenterology and highlighted the critical role gut homeostasis plays in the maintenance of 
human health. However, although probiotic research has been at the forefront of scientific 
research, some fundamental concepts have been overlooked and require investigation to complete 
our understanding of probiotic-host interactions. One of these fundamental concepts was partially 
addressed within this study, namely probiotic biofilm formation. The species and strain variability 
with regard to static lactobacilli biofilm formation was clearly illustrated. This, coupled to the 
differential effect of media composition on biofilm accumulation, emphasizes the requirement for 
strain and media specific evaluation of probiotic lactobacilli biofilm formation. 
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The transition from static lactobacilli biofilm cultivation to biofilm formation in a dynamic system, 
highlighted the lack of understanding with respect to lactobacilli biofilm development. The 
formation of static biofilms by both L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 in modified 
MRS (glucose replaced with gluconate) was minimal. However, during biofilm studies conducted 
under dynamic flow conditions (CEMS) using modified MRS, notable biofilm accumulation was 
observed and rapid recovery in biofilm activity was recorded after exposure to detrimental 
environmental conditions. This alludes to the requirement for probiotic (lactobacilli) biofilm 
studies to be conducted not only under static conditions, but also under dynamic flow conditions 
that better simulate the biotic environment. 
  
One of the major outcomes derived from this study was the differential survival response observed 
between planktonic and sessile lactobacilli populations to stress conditions. The vast majority of 
probiotic gastrointestinal fluid survival studies is conducted on planktonic microbial cells and 
ignores the importance and prevalence of sessile microbial populations. The difference in survival 
in response to gastrointestinal fluid induced stress between planktonic and sessile populations of 
both L. reuteri HFI-LD5 and L. rhamnosus HFI-K2 was clearly observed in this study. This 
illustrates the fact that populations derived from genetically identical microorganisms are capable 
of exhibiting differential responses. It is well established that distinct epigenetic, phenotypic and 
population variations exist between biofilm and free-living populations of microbial cells, which 
may explain the dissimilar responses. Based on this and the understanding garnered in this study, 
the case for examining probiotic microorganisms as biofilms under dynamic flow conditions is 
made clear.  
 
Despite the progress made with respect to our understanding of probiotics and their interaction 
with humans, a vast knowledge gap still exists. Probiotic microorganisms can no longer be seen 
as isolated, free-living cells but should rather be viewed in the context of multispecies biofilms, 
working in synergism to ensure survival and persistence within broader environments, and 
specifically within the human GIT. The need to reevaluate our experimental approaches to 
generate an understanding of probiotics in the context of sessile populations is clear, instead of 
simply extrapolating or forming assumptions based on planktonic studies.  
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Expansion based on current study 
 
To our knowledge, the current study was the first to examine probiotic (lactobacilli) biofilms under 
dynamic flow conditions and to assess the effects of simulated gastrointestinal fluids on the 
survival of biofilm-associated lactobacilli cells. A lack of original research studies in the field of 
probiotic biofilms has left many unanswered questions and as with any scientific study, this study 
has generated more questions than answers. It is however to be noted that the generation of new 
scientific questions and hypotheses, based on existing or newly generated scientific knowledge, is 
the cornerstone of science.  
 
This study has laid the foundation for future investigations of probiotic biofilms and the 
mechanisms underlying lactobacilli biofilm formation and development. The strain-specific nature 
of static biofilm formation as seen in this study and in others, clearly indicates the need to 
understand the fundamentals of lactobacilli biofilm formation. This aspect could be expanded to 
investigate lactobacilli biofilm formation on different surfaces (abiotic and biotic), with different 
properties (hydrophobic versus hydrophilic) and further determining whether it correlates to cell 
surface hydrophobicity. This has particular relevance to increasing biofilm formation under 
experimental conditions and reducing biofilm formation in industry, where it may be a significant 
problem.  
 
Structural analysis of lactobacilli biofilms should be assessed utilizing confocal laser scanning 
microscopy in conjunction with fluorescent stains or integrated proteins, for example. This avenue 
was partially explored during the course of this study, but required extensive optimization owing 
to a lack of knowledge around lactobacilli biofilms and attention was rather focused on the 
optimization of the CEMS system to monitor lactobacilli biofilm metabolism. Microscopic 
analysis of these biofilms could provide greater insight into biofilm form and function, as well as 
response to simulated gastric fluids.  
 
The presence of oxygen gradients in various GIT regions, along with the ability of most lactobacilli 
to grow in the absence or presence of oxygen, has led to the question of whether lactobacilli 
biofilms cultured under anaerobic, microaerophilic and aerobic environmental conditions would 
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exhibit altered biofilm properties and thus different stress responses. The feasibility of establishing 
lactobacilli biofilms in CEMS under anaerobic conditions was established during the beginning of 
this study, however it was decided to focus on the microaerophilic setup to first achieve a 
reproducible system prior to changing environmental parameters. Therefore with the establishment 
of a reproducible system, achieved by in this studies these different environmental parameters can 
be adequately and reproducibly assessed in future studies.   
 
Another aspect that needs to be adequately expanded on is the influence of media composition and 
individual media components on biofilm formation by lactobacilli. This expansion on the current 
work and that of others, will include investigating whether standard culture conditions, such as 
nutrient-rich MRS is conducive to biofilm formation, or whether nutrient deprivation is required. 
The role of carbon source and concentration and carbon to nitrogen ratio are critical aspects to 
consider, especially under stress conditions. It is also important to state that all of this fundamental 
biofilm work cannot be conducted solely using static biofilm systems, but should rather be done 
in conjunction with dynamic biofilm models, which provide a more realistic simulation of the 
natural environment. 
 
The human GIT is always in one of two states, either that of being fed or that of being in a state of 
fasting. This study only evaluated the effects of fasting-state gastrointestinal conditions on 
planktonic and biofilm-associated lactobacilli, owing to this representing the most extreme 
environment that lactobacilli in the human GIT might experience. It is therefore necessary that the 
interactions and stresses induced by fed-state gastrointestinal conditions on lactobacilli strains be 
assessed both under planktonic and sessile conditions. The simulation of fed-state gastrointestinal 
conditions would need to be assessed in two manners, namely the increased physiochemical and 
enzymatic conditions as well as these changes in conjunction with the addition of nutritional 
components/complete meal such as those contained in parenteral nutrition. The evaluation of the 
effects of fed-state on lactobacilli survival in vitro under both planktonic and sessile conditions 
may better our understanding as to the survival and persistence of probiotic microorganisms within 
the human GIT.  
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The question of biofilm-mucus interaction still remains unanswered with respect to lactobacilli 
and probiotics in general. It is well established that microorganisms used as probiotic supplements 
should preferentially interact with mucin but not possess mucinolytic activity. The standard 
procedure, as was conducted within this study, assesses the mucinolytic activity of planktonic 
cells. However, this fails to take into account potential mucinolytic activity induced by attachment 
to mucin. The known differential response of planktonic and biofilm-associated cells underscores 
the requirement of evaluating mucinolytic activity under both growth conditions. Therefore future 
studies in the probiotic-biofilm field will need to investigate whether sessile populations of 
probiotic microbes are capable of degrading and utilizing mucin as a nutrient source and whether 
the presence of mucin influences biofilm formation by these microorganisms. 
 
Even though a few basic studies relating to the field of probiotic biofilms have been published, 
these have done little more than to prove that lactobacilli spp. may form biofilms and emphasized 
the lack of scientific knowledge and understanding in the probiotic-biofilm field. This deficiency 
provides a novel field of scientific research, wherein classical and modern scientific approaches 
can be seamlessly integrated for the expansion of the probiotic and biofilm fields of scientific 
research. In return, a better understanding of the role of probiotics and probiotic biofilms in human 
health will be generated. It is hoped that this study lays the foundation for further studies into the 
fundamentals underpinning lactobacilli (probiotic) biofilm formation and to understanding 
commensal and probiotic interaction, survival and persistence within the human GIT.  
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